<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prevention and Anti-aging</title>
	<atom:link href="https://www.neolifesalud.com/en/secciones/prevention-and-anti-aging/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.neolifesalud.com/en/secciones/prevention-and-anti-aging/</link>
	<description>Medicina preventiva antiaging</description>
	<lastBuildDate>Wed, 19 Aug 2026 08:28:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://www.neolifesalud.com/wp-content/uploads/Neolife-2025-Circulosombra-150x150.png</url>
	<title>Prevention and Anti-aging</title>
	<link>https://www.neolifesalud.com/en/secciones/prevention-and-anti-aging/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">257710617</site>	<item>
		<title>21,000 People, Three Years, and a Daily Multivitamin: What the COSMOS Study Changed About Brain Health</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/21000-people-three-years-and-a-daily-multivitamin-what-the-cosmos-study-changed-about-brain-health/</link>
		
		<dc:creator><![CDATA[Dr. Martí]]></dc:creator>
		<pubDate>Wed, 19 Aug 2026 08:27:54 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[brain health]]></category>
		<category><![CDATA[COSMOS-Mind]]></category>
		<category><![CDATA[COSMOS-Web]]></category>
		<category><![CDATA[deterioro cognitivo]]></category>
		<category><![CDATA[estudio COSMOS]]></category>
		<category><![CDATA[Homocisteína]]></category>
		<category><![CDATA[longevity]]></category>
		<category><![CDATA[multivitamínico]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[vitaminas del grupo B]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/?p=31396</guid>

					<description><![CDATA[<p>The COSMOS study provides new evidence on the role of multivitamin supplements in healthy adults, after years of debate about their benefits. The finding that has attracted the most attention was not related to the heart or cancer, but to the brain: taking a daily multivitamin significantly reduced age-related cognitive decline across three independent study [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/21000-people-three-years-and-a-daily-multivitamin-what-the-cosmos-study-changed-about-brain-health/">21,000 People, Three Years, and a Daily Multivitamin: What the COSMOS Study Changed About Brain Health</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;"><strong>The COSMOS study provides new evidence on the role of multivitamin supplements in healthy adults, after years of debate about their benefits.</strong></h1>
<p style="text-align: justify;">The finding that has attracted the most attention was not related to the heart or cancer, but to the brain: taking a daily multivitamin significantly reduced age-related cognitive decline across three independent study groups. This is not definitive evidence, but it is the strongest evidence to date on the impact of this type of supplementation on brain health. </p>
<p style="text-align: justify;"><em> Dr. Carlos Martí – Neolife Medical Team</em></p>
<hr>
<p style="text-align: justify;"><strong>A Study Designed to Provide Answers, Not More Questions</strong></p>
<p style="text-align: justify;">COSMOS was designed at Harvard and led by Drs. JoAnn Manson and Shari Bassuk. More than 21,000 people over the age of 60 participated for almost four years: half took a daily <strong>multivitamin</strong>, while the other half took a placebo containing no active ingredients. Neither the participants nor the physicians responsible for follow-up knew which group they belonged to, eliminating the influence of expectations on the results.  </p>
<p style="text-align: justify;">What makes COSMOS particularly valuable in the field of brain health is that the same question was investigated in three different groups using different methods: one completed memory tests by telephone each year (COSMOS-Mind, more than 2,200 participants), another completed them online (COSMOS-Web, more than 3,500 participants), and a third group underwent detailed in-person assessments (COSMOS-Clinic, nearly 600 participants). The fact that all three reached the same conclusion is what makes this study more than just an isolated finding. </p>
<p style="text-align: justify;"><strong>What They Found: Memory Improved and Cognitive Decline Slowed</strong></p>
<p style="text-align: justify;">Across all three groups, people who took the <strong>multivitamin</strong> daily performed better on tests of memory and mental agility than those who took the placebo. The most frequently cited finding is that, in COSMOS-Mind, the multivitamin appeared to delay cognitive aging by approximately 1.8 years over a three-year follow-up period, equivalent to slowing cognitive decline by around 60%. </p>
<p style="text-align: justify;">The authors themselves are clear: the study has not demonstrated that a <strong>multivitamin</strong> prevents <strong>Alzheimer’s</strong> disease or reverses existing cognitive decline. What the results suggest is that it may act as a protective factor during the years before cognitive decline becomes noticeable. And that is precisely the stage at which there is still the greatest opportunity to intervene.  </p>
<p style="text-align: justify;"><img fetchpriority="high" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Multivitamin.jpg" alt="multivitamin" width="1024" height="683"></p>
<p style="text-align: justify;"><strong>Why the Brain May Respond Better Than the Heart</strong></p>
<p style="text-align: justify;">Previous studies involving tens of thousands of participants have investigated the effects of <strong>multivitamins</strong> on heart disease and cancer, without finding clear results. The <strong>brain</strong> appears to be a different case, and the reason is fairly intuitive: it is the body’s most energy-demanding organ and one of the organs that relies most heavily on vitamins to function properly on a daily basis. </p>
<p style="text-align: justify;">As we age, the absorption of some vitamins gradually becomes more difficult, while our needs do not necessarily decrease. A daily <strong>multivitamin</strong> could help fill the nutritional gap that even a reasonably varied diet does not always cover. COSMOS is the first large-scale study to provide real-world data—not just theoretical arguments—in support of this idea.  </p>
<p style="text-align: justify;"><strong>What the Study Does Not Say (and What You Should Know)</strong></p>
<p style="text-align: justify;">The results are real, but they should be interpreted in context. The <strong>multivitamin</strong> used in COSMOS was a standard generic product, so the study cannot determine which specific vitamins were responsible for the effect, nor whether a formulation containing higher-quality ingredients would have produced better or worse results. </p>
<p style="text-align: justify;">We also do not know whether the benefit persists beyond the three-year follow-up period, or whether it applies equally to people aged 45 and those aged 70. And although the observed difference was consistent, it was not enormous in everyday life: we are not talking about restoring the memory someone had twenty years ago, but rather about a protective effect that accumulates over time and makes much more sense as a sustained habit than as an effect that can be noticed from one day to the next. </p>
<p style="text-align: justify;"><strong>A Multivitamin Foundation as Part of a Longevity Program: The Role of NeoVitamin Plus</strong></p>
<p style="text-align: justify;">The practical conclusion from COSMOS is not that everyone should take a multivitamin. Rather, it suggests that in middle-aged and older adults whose diets are not always optimal, a daily vitamin foundation may have a favorable benefit-risk profile and, for the first time, solid experimental evidence supporting its potential role in cognitive health. This is precisely the type of intervention that makes sense within a <strong>preventive longevity program</strong>, where the goal is not to treat a disease but to preserve function before it begins to decline. </p>
<p style="text-align: justify;">At <strong>Neolife</strong>, we use <a href="https://neoactives.com/products/neovitamin-plus?variant=37968267837632"><strong>NeoVitamin Plus</strong> </a>as a vitamin foundation within this context. Its formulation includes B vitamins involved in homocysteine regulation (B6, active-form B12, folate, and betaine), antioxidant vitamins C and E, and nutrients such as choline, which are less common in standard multivitamin formulations. The study does not support any specific formulation, but the mechanisms highlighted by COSMOS are precisely those addressed by NeoVitamin Plus in the design of its formula. Because if there is one thing this trial makes clear, it is that the brain, like the rest of the body, is better cared for before it starts asking for help.   </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p>(1) Yeung LK, Alschuler DM, Wall M, Luttmann-Gibson H, Copeland T, Hale C, et al. Multivitamin supplementation improves memory in older adults: a randomized clinical trial. Am J Clin Nutr. 2023;118(1):273-282. doi: 10.1016/j.ajcnut.2023.05.011. [COSMOS-Web]     </p>
<p>(2) Vyas CM, Manson JE, Sesso HD, Cook NR, Moorthy MV, Buring JE, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COSMOS randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692-701. doi: 10.1016/j.ajcnut.2023.12.011. [COSMOS-Clinic + metáanálisis]     </p>
<p>(3) Manson JE, Bassuk SS, Cook NR, et al. COSMOS (COcoa Supplement and Multivitamin Outcomes Study): design and baseline characteristics of a randomized controlled trial. Contemp Clin Trials. 2020;94:106033. doi: 10.1016/j.cct.2020.106033.</p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/21000-people-three-years-and-a-daily-multivitamin-what-the-cosmos-study-changed-about-brain-health/">21,000 People, Three Years, and a Daily Multivitamin: What the COSMOS Study Changed About Brain Health</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">31396</post-id>	</item>
		<item>
		<title>Biological Age: How Old Is Your Body Really?</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/biological-age-how-old-is-your-body-really/</link>
		
		<dc:creator><![CDATA[Dra. López]]></dc:creator>
		<pubDate>Wed, 19 Aug 2026 07:26:20 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[biological age]]></category>
		<category><![CDATA[healthy habits]]></category>
		<category><![CDATA[longevity]]></category>
		<category><![CDATA[quality of life]]></category>
		<category><![CDATA[telomers]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/biological-age-how-old-is-your-body-really/</guid>

					<description><![CDATA[<p>Your ID card tells you how many years you have lived. Your biological age helps us understand how you are living those years and what you can do to age better. We all know our chronological age, but two people born in the same year can have very different levels of health. Biological clocks analyze [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/biological-age-how-old-is-your-body-really/">Biological Age: How Old Is Your Body Really?</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;"><strong>Your ID card tells you how many years you have lived. Your biological age helps us understand how you are living those years and what you can do to age better. </strong></h1>
<p style="text-align: justify;">We all know our chronological age, but two people born in the same year can have very different levels of health. Biological clocks analyze different signals from the body to provide a more personalized picture of how we are aging. </p>
<p style="text-align: justify;"><em> Dr. Marta López – Neolife Medical Team </em></p>
<hr>
<p style="text-align: justify;"><strong><span lang="EN-US">Chronological Age and Biological Age Are Not the Same</span></strong></p>
<p style="text-align: justify;"><strong>Chronological age</strong> is straightforward: it is the number of years that have passed since we were born. It cannot be changed and progresses at the same rate for everyone. </p>
<p style="text-align: justify;"><strong>Biological age</strong> tries to answer a different question: how is our body doing for our age? We see this constantly in clinical practice. There are 60-year-olds with excellent physical capacity, good muscle mass, and optimal metabolic parameters, while others of the same age may experience greater fatigue, inflammation, loss of strength, or several risk factors.  </p>
<p style="text-align: justify;">That is why, when we talk about <strong>longevity</strong>, we are not only interested in adding years to life. We want to understand how we are reaching those years and what we can do to maintain energy, independence, and <strong>quality of life</strong> for longer. </p>
<p style="text-align: justify;"><strong>Living Longer and Living Better: Lifespan vs. Healthspan</strong></p>
<p style="text-align: justify;">In longevity medicine, we distinguish between two closely related concepts. Lifespan is the total length of life: how many years we live. Healthspan, on the other hand, is the amount of time we live in good <strong>health</strong>, with independence, energy, and the ability to carry out our daily lives normally. It is not simply about adding more years to the calendar, but about making as many of those years as possible years of quality. Knowing our biological age can help us identify which areas deserve greater attention in order to bring these two goals closer together: living longer, but above all, living better.    </p>
<p style="text-align: justify;"><strong><span lang="EN-US">What Influences Our Biological Age?</span></strong></p>
<p style="text-align: justify;">Our genes play an important role, but they do not tell the whole story. Diet, exercise, sleep, stress, body composition, and exposure to toxins also leave their mark on the body. </p>
<p>This is good news: we cannot change our date of birth, but we can influence many of the factors that affect how <strong>we age</strong>.</p>
<p style="text-align: justify;"><img decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Edad-biologica.png" alt="biological age" width="1024" height="683"></p>
<p style="text-align: justify;"><strong><span lang="EN-US">Biological Clocks: A Snapshot of How We Are Aging</span></strong></p>
<p style="text-align: justify;">Biological clocks are tools that combine different biomarkers and transform them into an estimate of biological age or <strong>aging</strong> rate.</p>
<p style="text-align: justify;">We could compare them to a car&#8217;s dashboard. The number of kilometers tells us something, but we also want to know the condition of the engine, fuel consumption, tire pressure, or whether there are any warning signals. Something similar happens in our bodies: chronological age is an important piece of information, but it is not the only one.  </p>
<p style="text-align: justify;">There are clocks based on clinical tests, proteins, metabolites, medical imaging, or data collected through digital devices. Among the best known are epigenetic clocks, which analyze certain chemical signals in DNA associated with the passage of time, health status, and lifestyle. </p>
<p style="text-align: justify;"><strong><span lang="EN-US">Epigenetics: When Lifestyle Communicates with Our Genes</span></strong></p>
<p style="text-align: justify;"><strong>Epigenetics</strong> studies how gene activity is regulated without changing the DNA sequence itself. One simple way to understand it is to imagine that DNA is a large instruction manual. Epigenetics helps determine which pages are read more, which are read less, and how the body responds to its environment.  </p>
<p style="text-align: justify;">Diet, physical activity, rest, stress, smoking, and metabolic health can all be associated with epigenetic changes. Based on these signals, epigenetic clocks estimate whether our body shows a pattern of <strong>aging</strong> that is faster, similar to, or slower than expected for our chronological age. </p>
<p style="text-align: justify;">The value of this information is not simply knowing a number. Its importance lies in using it as a starting point to review our habits, identify areas for improvement, and develop a more personalized health strategy. </p>
<p style="text-align: justify;"><strong><span lang="EN-US">Telomeres: Protectors of Our Chromosomes</span></strong></p>
<p style="text-align: justify;"><strong>Telomeres </strong>are structures located at the ends of chromosomes. Their function is similar to the small plastic tips that protect the ends of shoelaces: they help prevent genetic material from deteriorating. </p>
<p style="text-align: justify;">As time passes and cells undergo successive divisions, telomeres tend to shorten. Their length is influenced by age, but it has also been associated with oxidative stress, inflammation, smoking, sedentary behavior, and other <strong>health </strong>factors. </p>
<p style="text-align: justify;"><strong>Measuring telomere length</strong> provides information about <strong>cellular aging </strong>and adds another piece to the set of data we use to assess how a person is aging.</p>
<p style="text-align: justify;"><strong><span lang="EN-US">Can We Improve Our Biological Age?</span></strong></p>
<p style="text-align: justify;">Biological age should not be understood as a sentence or a fixed label. Its greatest value lies precisely in reminding us that a significant part of how we age is related to modifiable factors. </p>
<p style="text-align: justify;">There are simple measures, although not always easy to maintain, that can make a significant difference:</p>
<ul>
<li style="text-align: justify;">Maintain good muscle mass and engage in strength training.</li>
<li>Exercise regularly and take care of cardiovascular fitness.</li>
<li>Follow a diet adapted to your individual needs.</li>
<li>Sleep well and maintain healthy rest patterns.</li>
<li>Monitor glucose, blood pressure, cholesterol, and body composition.</li>
<li>Reduce smoking, excessive alcohol consumption, and exposure to other toxins.</li>
<li>Take care of stress, emotional health, and social relationships.</li>
</ul>
<p style="text-align: justify;">Measuring allows us to better understand our starting point. And when we repeat an assessment after some time, we can also observe changes and determine whether the modifications we have introduced are moving us in the right direction. </p>
<p style="text-align: justify;"><strong><span lang="EN-US">The Neolife Approach: Measure to Take Action</span></strong></p>
<p style="text-align: justify;">At <strong>Neolife</strong>, we understand <strong>longevity medicine</strong> as <strong>preventive, personalized</strong>, and data-driven medicine. Our aim is not simply to know how old a person is, but to understand their current health status and identify the areas we can work on to improve their future health. </p>
<p style="text-align: justify;">As part of our assessment, we offer two tests specifically related to biological age:</p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Telomere length measurement:</strong> provides information about cellular aging and the condition of these protective structures at the ends of our chromosomes.</li>
<li style="text-align: justify;"><strong>Epigenetic biological age test</strong>: analyzes epigenetic signals associated with aging and helps assess how our lifestyle may be influencing this process.</li>
</ul>
<p style="text-align: justify;">We interpret these results alongside the patient&#8217;s medical history, blood tests, body composition, cardiovascular health, muscle mass, exercise, sleep, and lifestyle. In this way, the number stops being an isolated piece of data and becomes a tool for making informed decisions. </p>
<p style="text-align: justify;">Knowing our <strong>biological age</strong> does not mean predicting the future. It means having more information to take better care of it. Because the goal is not simply to live more years, but to reach those years with greater health, independence, and quality of life.  </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p>(1) de Magalhães JP. <em>Biological aging clocks in health and disease</em>. Nature Medicine.   2026. doi:10.1038/s41591-026-04495-3.</p>
<p>(2) Mavrommatis C, et al. <em>An unbiased comparison of 14 epigenetic clocks in relation to 174 incident disease outcomes</em>. Nature Communications. 2025;16:11164. doi:10.1038/s41467-025-66106-y.   </p>
<p>(3) Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. doi:10.7554/eLife.73420.    </p>
<p>(4) Horvath S. <em>DNA methylation age of human tissues and cell types</em>. Genome Biology. 2013;14:R115. doi:10.1186/gb-2013-14-10-r115.   </p>
<p>(5) Levine ME, et al. <em>An epigenetic biomarker of aging for lifespan and healthspan</em>. Aging. 2018;10(4):573-591. doi:10.18632/aging.101414.</p>
<p>(6) Vaiserman A, Krasnienkov D. <em>Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives</em>. Frontiers in Genetics. 2021;11:630186. doi:10.3389/fgene.2020.630186.</p>
<p>(7) Wang K, et al. <em>A full life cycle biological clock based on routine clinical data and its impact in health and diseases.</em> Nature Medicine. 2025. doi:10.1038/s41591-025-04006-w.</p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/biological-age-how-old-is-your-body-really/">Biological Age: How Old Is Your Body Really?</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">31382</post-id>	</item>
		<item>
		<title>Vitamin D: An Evidence-Based Pillar of Longevity</title>
		<link>https://www.neolifesalud.com/en/blog/supplementation/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging/</link>
		
		<dc:creator><![CDATA[Dra. Junyent]]></dc:creator>
		<pubDate>Wed, 29 Jul 2026 09:54:23 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[Supplementation]]></category>
		<category><![CDATA[Vitamina D · Colecalciferol · 4.000 UI · Healthy Aging · Longevidad · Fragilidad · Función muscular · Déficit de vitamina D · 25(OH)D · Metaanálisis]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging/</guid>

					<description><![CDATA[<p>Vitamin D3 supplementation, including doses of up to 4,000 IU/day in selected patients, has emerged as a safe and effective strategy to correct deficiency and preserve musculoskeletal health during aging. Vitamin D deficiency remains highly prevalent, even in Mediterranean countries. The latest evidence supports an individualized approach to supplementation, highlighting that doses of up to [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/supplementation/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging/">Vitamin D: An Evidence-Based Pillar of Longevity</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr />
<h1 style="text-align: justify;"><strong>Vitamin D3 supplementation, including doses of up to 4,000 IU/day in selected patients, has emerged as a safe and effective strategy to correct deficiency and preserve musculoskeletal health during aging.</strong></h1>
<p style="text-align: justify;">Vitamin D deficiency remains highly prevalent, even in Mediterranean countries. The latest evidence supports an individualized approach to supplementation, highlighting that doses of up to 4,000 IU/day may be necessary to achieve optimal 25(OH)D concentrations in certain patients. Beyond its well-established role in bone metabolism, vitamin D is increasingly recognized as an important contributor to healthy aging.</p>
<p style="text-align: justify;"><em> Dr. Mireia Junyent – Neolife Medical Team </em></p>
<hr />
<p style="text-align: justify;"><strong>Why Is Vitamin D Deficiency Still So Common?</strong></p>
<p style="text-align: justify;">Despite the abundant sunlight typical of Mediterranean regions, <strong>vitamin D</strong> insufficiency continues to represent a significant public health issue. A substantial proportion of adults have inadequate 25-hydroxyvitamin D levels, particularly older adults, individuals with obesity, gastrointestinal disorders, limited sun exposure, or darker skin phototypes.</p>
<p style="text-align: justify;"><strong>Aging</strong> reduces the skin&#8217;s ability to synthesize vitamin D, increasing the risk of chronic insufficiency that may negatively affect musculoskeletal health and physical function.</p>
<p style="text-align: justify;">Recent meta-analyses consistently show that conventional supplementation doses (600–800 IU/day) may be insufficient to achieve adequate serum levels in patients with risk factors, reinforcing the importance of personalized <strong>supplementation</strong> strategies.</p>
<p style="text-align: justify;"><img decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/VitD3-scaled.jpg" alt="VitD3" width="1024" height="683" /></p>
<p style="text-align: justify;"><strong>4,000 IU/Day: An Evidence-Based Dose</strong></p>
<p style="text-align: justify;">Current recommendations emphasize that the optimal vitamin D dose should be tailored to each individual&#8217;s characteristics. Multiple clinical trials and systematic reviews have demonstrated that supplementation with 4,000 <strong>IU/day of cholecalciferol </strong>(vitamin D3) is more effective at correcting <strong>vitamin D</strong> deficiency than standard doses, particularly in patients with obesity, older age, or malabsorption.</p>
<p style="text-align: justify;">This regimen has been shown to provide:</p>
<ul>
<li>A greater likelihood of achieving serum 25(OH)D concentrations &gt; 30 ng/mL.</li>
<li>Improved response in patients with increased volume of distribution or reduced bioavailability.</li>
<li>An excellent safety profile when prescribed and monitored by healthcare professionals.</li>
<li>No clinically significant increase in hypercalcemia in the available studies.</li>
</ul>
<p style="text-align: justify;">The most recent clinical practice guidelines consider 4,000 IU/day to be the upper tolerable intake level for healthy adults and a commonly used dosage in vitamin D deficiency correction protocols before transitioning to a maintenance regimen.</p>
<p style="text-align: justify;"><strong>Vitamin D and Healthy Aging: Beyond Bone Health</strong></p>
<p style="text-align: justify;">Over the past decade, <strong>vitamin D</strong> has evolved from being viewed solely as a regulator of calcium and phosphorus metabolism to becoming an important component of <strong>longevity</strong> medicine.</p>
<p style="text-align: justify;"><strong>Aging </strong>is associated with a progressive decline in muscle mass, immune system changes, and a chronic low-grade inflammatory state known as inflammaging. Within this context, maintaining adequate vitamin D levels may help preserve musculoskeletal function and support <em>healthy</em> <strong>aging</strong>.</p>
<p style="text-align: justify;">The strongest evidence supports benefits in:</p>
<ul>
<li style="text-align: justify;">Maintaining muscle strength and physical function.</li>
<li>Reducing the risk of frailty.</li>
<li>Preserving mobility in older adults.</li>
<li>Optimizing bone health and reducing the risk of osteomalacia.</li>
</ul>
<p style="text-align: justify;">Although several studies have linked adequate vitamin D levels with improved immune function, lower systemic inflammation, and better cardiometabolic health, current evidence does not support recommending vitamin D supplementation specifically as an intervention to slow biological aging or extend lifespan.</p>
<p style="text-align: justify;">From a clinical perspective, correcting vitamin D deficiency should therefore be considered a strategy to optimize overall <strong>health </strong>and functional capacity rather than an &#8220;anti-aging&#8221; treatment.</p>
<p style="text-align: justify;">At Neolife, we offer <a href="https://neoactives.com/products/neovit-d3?srsltid=AfmBOoro7HO0jso-txH9SDefLiLc7WbKDYKi6pMv25ZzwlYHrUjhmd2r">NeoVit D3</a>, a high-quality vitamin D3 supplement formulated to help maintain optimal vitamin D levels. Our medical team can assess your individual needs and recommend the most appropriate supplementation strategy based on your clinical profile.</p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NeoVitD3.webp" alt="NeoVitD3" width="1024" height="683" /></p>
<hr />
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) Demay MB, et al. <strong>Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline.</strong> <em>J Clin Endocrinol Metab.</em></p>
<p style="text-align: justify;">(2) Bouillon R. <strong>Vitamin D and Healthy Aging.</strong> <em>Nature Reviews Endocrinology.</em></p>
<p style="text-align: justify;">(3) Ortiz-Prado E, et al. <strong>Cholecalciferol (vitamin D3): efficacy, safety and implications in public health.</strong> <em>Front Nutr.</em></p>
<p style="text-align: justify;">(4) Ogorek AN, Samara VA. <strong>New Clinical Practice Guidelines for Vitamin D Supplementation and Testing.</strong> <em>Clin Chem.</em></p>
<p style="text-align: justify;">(5) Goswami C, et al. <strong>Are there prophylactic effects of vitamin D among healthier adults? A systematic review of randomized controlled trials. </strong> <em>BMC Nutrition.</em></p>
<p style="text-align: justify;">(6) <strong>Figura 1.</strong> Metabolismo de la vitamina D y formación de 25(OH)D y calcitriol. Adaptado de Ortiz-Prado et al. <em>Front Nutr.</em> 2025 (CC BY).</p>
<hr />
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/supplementation/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging/">Vitamin D: An Evidence-Based Pillar of Longevity</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">31340</post-id>	</item>
		<item>
		<title>A First Marathon, A Younger Aorta: What a Group of Recreational Runners in London Demonstrated</title>
		<link>https://www.neolifesalud.com/en/blog/neolife-en/a-first-marathon-a-younger-aorta-what-a-group-of-recreational-runners-in-london-demonstrated/</link>
		
		<dc:creator><![CDATA[Dr. Martí]]></dc:creator>
		<pubDate>Wed, 15 Jul 2026 06:41:47 +0000</pubDate>
				<category><![CDATA[Neolife]]></category>
		<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[aortic stiffness]]></category>
		<category><![CDATA[cardiovascular health]]></category>
		<category><![CDATA[cardiovascular longevity]]></category>
		<category><![CDATA[endurance training]]></category>
		<category><![CDATA[envejecimiento]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[recreational marathon]]></category>
		<category><![CDATA[Sphygmocor]]></category>
		<category><![CDATA[vascular age]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/a-first-marathon-a-younger-aorta-what-a-group-of-recreational-runners-in-london-demonstrated/</guid>

					<description><![CDATA[<p>One of the most widely discussed studies in recent preventive cardiology, involving first-time runners in the London Marathon, examined how six months of training affected aortic health. The study, published in the Journal of the American College of Cardiology and funded by the British Heart Foundation, included 138 runners and showed that marathon preparation reduced [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/neolife-en/a-first-marathon-a-younger-aorta-what-a-group-of-recreational-runners-in-london-demonstrated/">A First Marathon, A Younger Aorta: What a Group of Recreational Runners in London Demonstrated</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;">One of the most widely discussed studies in recent preventive cardiology, involving first-time runners in the London Marathon, examined how six months of training affected aortic health.</h1>
<p style="text-align: justify;">The study, published in the Journal of the American College of Cardiology and funded by the British Heart Foundation, included 138 runners and showed that marathon preparation reduced aortic stiffness and central blood pressure. Participants achieved arterial rejuvenation equivalent to approximately four years, with the greatest benefits observed in those who began with poorer physical fitness. </p>
<p style="text-align: justify;"><em> Dr. Carlos Martí – Neolife Medical Team</em></p>
<hr>
<p style="text-align: justify;"><strong>The aorta: the forgotten shock absorber of the circulatory system</strong></p>
<p style="text-align: justify;">When <strong>cardiovascular health</strong> is discussed, attention usually focuses on the heart or on specific arteries such as the coronary arteries. The <strong>aorta</strong> tends to remain in the background despite being the body&#8217;s largest artery and being responsible for a little-known but essential function: cushioning the force of each heartbeat. In a young person, its wall is elastic thanks to the elastin fibers that compose it, and it expands and recoils with every contraction of the heart, transforming a pulsatile flow into a much more uniform one before it reaches the rest of the body.  </p>
<p>With age, that elastin is gradually degraded and replaced by collagen, a much stiffer protein. The aorta loses its cushioning capacity, the pressure generated by each heartbeat reaches the brain, heart, and kidneys with greater force, and this ongoing mechanical wear underlies much of the increased risk of hypertension, stroke, and heart failure associated with <strong>aging</strong>, even in the absence of other identifiable risk factors. </p>
<p style="text-align: justify;"><strong>The most surprising finding: the poorer the starting fitness, the greater the benefit</strong></p>
<p style="text-align: justify;">When the results were analyzed by subgroup, a pattern emerged that overturns the usual intuition about exercise and age: <strong>vascular rejuvenation</strong> was not greatest in the youngest or fastest runners, but rather in the older participants and those with slower finishing times. The stiffer the aorta was at the beginning of the study, the greater the improvement observed after six months of training. </p>
<p style="text-align: justify;">The authors&#8217; interpretation was clear and, for any sedentary person considering starting exercise after the age of 50 or 60, quite encouraging: the cardiovascular system retains a substantial capacity for adaptation throughout much of adult life, and one does not need to have been an athlete to benefit. In fact, the margin for improvement is often greatest precisely in those who start from a less favorable baseline. </p>
<p style="text-align: justify;"><strong>How vascular age is measured today: from the research laboratory to the clinic</strong></p>
<p style="text-align: justify;">In the original study, <strong>aortic stiffness</strong> was measured using cardiovascular magnetic resonance imaging, a highly precise technique that, because of its cost and availability, is largely confined to research settings. To bring the same concept into clinical practice, the reference tool is pulse wave velocity (PWV): the speed at which the pressure wave generated by each heartbeat travels through the arteries. A stiffer arterial wall transmits that wave more quickly, making an elevated PWV an independent predictor of cardiovascular risk beyond traditional risk factors.  </p>
<p style="text-align: justify;">Devices such as <strong>SphygmoCor</strong> can obtain this measurement non-invasively using a blood-pressure cuff on the arm or tonometry sensors placed over the radial and femoral arteries, reconstructing the central aortic pressure waveform without any invasive procedure. This turns something that previously could only be estimated indirectly into an objective, reproducible measurement: a true snapshot of the biological age of the arterial system, useful both for detecting accelerated vascular aging and for assessing whether an intervention such as a training program is working. </p>
<p style="text-align: justify;"><strong>What endurance exercise does that a drug cannot fully replicate</strong></p>
<p style="text-align: justify;">The mechanism behind this improvement is not a single factor but the sum of several. Sustained endurance exercise increases shear stress on the endothelium, the inner lining of blood vessels, which stimulates the production of nitric oxide, a molecule central to the arteries&#8217; ability to relax and remain elastic. Added to this are the well-documented effects of aerobic exercise: lower blood pressure, improved lipid profile, reduced low-grade inflammation, and greater insulin sensitivity.  </p>
<p style="text-align: justify;">What this study contributed was not the discovery that exercise improves <strong>vascular health</strong>—that has been known for years from supervised laboratory training programs—but the demonstration that the same benefit can be achieved through real-world training, without clinical supervision and at moderate intensity, the kind of program followed by anyone who decides to run a first marathon.</p>
<p style="text-align: justify;"><strong>From evidence to practice: what this means for someone starting from zero</strong></p>
<p style="text-align: justify;">Translated into a realistic plan, the training pattern followed by the study participants did not require becoming a competitive distance runner: gradual progression of training volume over several months, three to five sessions per week combining easy continuous running with some more demanding work, and consistency maintained over time. The reported benefit was achieved after six months of preparation, not through isolated efforts or occasional high-intensity sessions. </p>
<p style="text-align: justify;">In sedentary individuals, in those with pre-existing <strong>cardiovascular risk </strong>factors, or in adults over 45–50 years of age, it is advisable to begin with a medical evaluation that includes basic cardiovascular screening before starting a program of this type. Knowing a patient&#8217;s true vascular age at baseline, rather than relying solely on a single blood-pressure reading taken in the office, provides much more comprehensive information and also allows objective monitoring of progress as training advances. </p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Rigidez-arterial-2.jpg" alt="Arterial stiffness" width="1024" height="683"></p>
<p style="text-align: justify;"><strong>As always, the Neolife approach</strong></p>
<p style="text-align: justify;">This study illustrates a central idea in <strong>preventive and longevity <strong>medicine</strong></strong>: biological age does not always match the age printed on an ID card, and much of that difference depends on modifiable factors. At Neolife, <strong>our preventive checkups</strong> include the assessment of cardiovascular biomarkers, including indicators of arterial stiffness, precisely to understand each patient&#8217;s true baseline beyond a blood-pressure number measured at a single moment. </p>
<p style="text-align: justify;">Based on that assessment, we design personalized follow-up programs that combine exercise prescription, nutrition, and medical intervention when necessary, with the aim of addressing the aspects of vascular aging that can be modified. The study by Bhuva and Manisty leaves a simple message that is easy to apply: sometimes, the path toward a younger aorta begins with setting a first goal, no matter how distant it may seem at the start. </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) Bhuva AN, D&#8217;Silva A, Torlasco C, Jones S, Nadarajan N, Van Zalen J, et al. Training for a First-Time Marathon Reverses Age-Related Aortic Stiffening. J Am Coll Cardiol. 2020;75(1):60-71. doi: 10.1016/j.jacc.2019.10.045.    </p>
<p style="text-align: justify;">(2) University College London Hospitals Biomedical Research Centre. Training for first-time marathon “reverses” ageing of blood vessels. Comunicado de prensa, mayo de 2019.  </p>
<p style="text-align: justify;">(3) Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015;66(3):698-722.   </p>
<p style="text-align: justify;">(4) Butlin M, Qasem A. Large Artery Stiffness Assessment Using SphygmoCor Technology. Pulse (Basel). 2017;4(4):180-192.  </p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/neolife-en/a-first-marathon-a-younger-aorta-what-a-group-of-recreational-runners-in-london-demonstrated/">A First Marathon, A Younger Aorta: What a Group of Recreational Runners in London Demonstrated</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">31319</post-id>	</item>
		<item>
		<title>Osteoporosis and Nutrition: What to Avoid and How to Protect Your Bones</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/osteoporosis-and-nutrition-what-to-avoid-and-how-to-protect-your-bones/</link>
		
		<dc:creator><![CDATA[Meritxell Massons]]></dc:creator>
		<pubDate>Mon, 16 Mar 2026 10:44:56 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[age]]></category>
		<category><![CDATA[bone formation]]></category>
		<category><![CDATA[bone health]]></category>
		<category><![CDATA[bones]]></category>
		<category><![CDATA[estrógenos]]></category>
		<category><![CDATA[menopausia]]></category>
		<category><![CDATA[osteopenia]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[peak bone mass]]></category>
		<category><![CDATA[postmenopausal women]]></category>
		<category><![CDATA[supplementation]]></category>
		<category><![CDATA[testosterone]]></category>
		<category><![CDATA[vitamina D]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/osteoporosis-and-nutrition-what-to-avoid-and-how-to-protect-your-bones/</guid>

					<description><![CDATA[<p>Osteoporosis and osteopenia are silent diseases that affect millions of people, especially as they age. Diet, lifestyle, and certain daily habits play a key role in both their prevention and progression. In this article, we review what happens in the bones, which nutrients help protect them, and which foods should be limited to preserve their [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/osteoporosis-and-nutrition-what-to-avoid-and-how-to-protect-your-bones/">Osteoporosis and Nutrition: What to Avoid and How to Protect Your Bones</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;">Osteoporosis and osteopenia are silent diseases that affect millions of people, especially as they age.</h1>
<p style="text-align: justify;">Diet, lifestyle, and certain daily habits play a key role in both their prevention and progression. In this article, we review what happens in the bones, which nutrients help protect them, and which foods should be limited to preserve their strength. </p>
<p style="text-align: justify;"><em> Meritxell Massons – Neolife Nutrition Unit</em></p>
<hr>
<p style="text-align: justify;"><strong>What Are Osteoporosis and Osteopenia?</strong></p>
<p style="text-align: justify;">Osteoporosis is a disease characterized by the progressive loss of bone mass and bone quality. The bone becomes more porous and fragile, significantly increasing the risk of fractures, even during everyday activities such as walking or bending down. </p>
<p style="text-align: justify;"><strong>Osteopeni</strong>a is a previous stage in which bone mineral density is lower than normal but does not yet meet the diagnostic criteria for osteoporosis. It is usually detected through a bone densitometry test and represents an important opportunity for prevention. </p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Osteoporosis-1.png" alt="osteoporosis" width="1024" height="683"></p>
<p style="text-align: justify;"><strong>Why Do Bones Weaken With Age?</strong></p>
<p style="text-align: justify;"><strong>Bones</strong> are not static structures; they are constantly being renewed. Some cells build bone (osteoblasts), while others break it down (osteoclasts). </p>
<ul>
<li style="text-align: justify;"><strong>Childhood and adolescence:</strong> bone formation predominates.</li>
<li><strong>Adulthood:</strong> a balance is maintained between formation and degradation.</li>
<li><strong>After the age of 50–60</strong>: degradation exceeds formation, especially after menopause due to the decline in estrogen levels.</li>
</ul>
<p style="text-align: justify;">This process explains why osteoporosis is more common in <strong>postmenopausal women</strong> and <strong>older </strong>men.</p>
<p style="text-align: justify;"><strong>Preventing Osteoporosis Through Nutrition</strong></p>
<p style="text-align: justify;">Prevention begins long before symptoms appear. Achieving a good <strong>peak bone mass</strong> during adolescence and early adulthood is essential for long-term <strong>bone health</strong>. </p>
<p style="text-align: justify;"><strong>Calcium: The Structural Basis of Bone</strong></p>
<p style="text-align: justify;">Adequate calcium intake prevents the body from extracting calcium from bones to maintain vital functions such as muscle contraction or blood clotting.</p>
<p style="text-align: justify;"><u>Main sources:</u></p>
<ul>
<li style="text-align: justify;">Dairy products (milk, yogurt, aged and semi-aged cheeses)</li>
<li>Legumes, nuts, and seeds</li>
<li>Small fish eaten with bones (such as sardines)</li>
<li>Vegetables such as broccoli</li>
<li>Fortified foods (plant-based drinks, cereals)</li>
</ul>
<p style="text-align: justify;">Two daily servings of dairy products, within a varied diet, usually cover the needs of healthy adults.</p>
<p style="text-align: justify;"><strong>Vitamin D: Essential for Calcium Absorption</strong></p>
<p style="text-align: justify;"><strong>Vitamin D</strong> allows calcium to be properly absorbed in the intestine and deposited in the bone.</p>
<p style="text-align: justify;"><u>Main sources:</u></p>
<ul>
<li style="text-align: justify;">Moderate sun exposure</li>
<li>Oily fish</li>
<li>Eggs and dairy products</li>
<li>Fortified foods</li>
</ul>
<p style="text-align: justify;">During winter or in individuals with limited sun exposure, deficiencies are common, and <strong>supplementation</strong> may be necessary under the supervision of a healthcare professional.</p>
<p style="text-align: justify;"><strong>Physical Activity: An Essential Stimulus</strong></p>
<p style="text-align: justify;">Exercise, especially weight-bearing activities (walking, climbing stairs, dancing, or strength training), stimulates <strong>bone formation</strong>. Each muscle contraction sends a positive signal to the bone, helping maintain its density. </p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Osteoporosis-3-1.png" alt="osteoporosis" width="1024" height="683"></p>
<p style="text-align: justify;"><strong>Nutrients That Support Bone Health</strong></p>
<p style="text-align: justify;">In addition to calcium and vitamin D, other nutrients play key roles:</p>
<ul>
<li style="text-align: justify;"><strong>Protein:</strong> necessary for the bone matrix, although excessive intake from animal sources should be avoided.</li>
<li><strong>Magnesium:</strong> supports bone mineralization and hormonal activity.</li>
<li><strong>Zinc: </strong>involved in the formation and repair of bone tissue.</li>
<li><strong>Vitamin C</strong>: essential for collagen synthesis.</li>
<li><strong>Vitamin K:</strong> regulates calcium binding in bone.</li>
</ul>
<p style="text-align: justify;">A varied and balanced diet usually covers these requirements.</p>
<p style="text-align: justify;"><strong>Foods and Substances to Limit in Osteoporosis</strong></p>
<p style="text-align: justify;">This does not mean strict prohibitions, but rather moderate and mindful consumption.</p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Caffeine</strong></li>
</ul>
<p style="text-align: justify;">High intake may increase urinary calcium excretion. Limiting coffee, tea, and energy drinks can help protect bone health. </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Excess Phosphorus</strong></li>
</ul>
<p style="text-align: justify;">Found mainly in soft drinks such as cola and in ultra-processed foods. Excess phosphorus disrupts the calcium–phosphorus balance and negatively affects bone density. </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Alcohol and Tobacco</strong></li>
</ul>
<p style="text-align: justify;">Both interfere with new bone formation and increase the risk of fractures. Reducing or eliminating them is a key preventive measure. </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Phytates and Oxalates</strong></li>
</ul>
<p style="text-align: justify;">Present in whole grains, cocoa, coffee, and some leafy green vegetables. It is not necessary to eliminate them, but it is advisable to combine them appropriately and ensure they do not displace calcium-rich foods. </p>
<p style="text-align: justify;"><strong>Nutrition and Hormones: A Key Relationship</strong></p>
<p style="text-align: justify;">The loss of <strong>estrogen</strong> during <strong>menopause</strong> and <strong>testosterone </strong>in older men accelerates bone loss. For this reason, osteoporosis is more common in postmenopausal women and in men over the age of 65. </p>
<p style="text-align: justify;">Proper nutrition, together with exercise and medical monitoring, can significantly slow this process.</p>
<p style="text-align: justify;"><strong>Conclusion</strong></p>
<p style="text-align: justify;">Taking care of bone health does not depend on a single food, but on an overall lifestyle. A nutrient-rich diet, regular physical activity, and reducing harmful habits are the best tools to prevent osteoporosis and improve quality of life in the long term. </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) World Health Organization. <em>Prevention and management of osteoporosis: report of a WHO scientific group</em>. Geneva: World Health Organization; 2003. (WHO Technical Report Series; no. 921).  </p>
<p style="text-align: justify;">(2) International Osteoporosis Foundation. <em>Nutrition and bone health</em> [Internet]. Nyon: International Osteoporosis Foundation; 2023 [cited 2026 Feb 9]. Available from: International Osteoporosis Foundation.  </p>
<p style="text-align: justify;">(3) National Institutes of Health, Office of Dietary Supplements. <em>Calcium: fact sheet for health professionals</em> [Internet]. Bethesda (MD): National Institutes of Health; 2022 [cited 2026 Feb 9]. Available from: National Institutes of Health.  </p>
<p style="text-align: justify;">(4) National Institutes of Health, Office of Dietary Supplements. <em>Vitamin D: fact sheet for health professionals</em> [Internet]. Bethesda (MD): National Institutes of Health; 2022 [cited 2026 Feb 9]. Available from: National Institutes of Health.  </p>
<p style="text-align: justify;">(5) European Food Safety Authority. Scientific opinion on dietary reference values for calcium. <em>EFSA Journal</em>. 2015;13(5):4101.  </p>
<p style="text-align: justify;">(6) European Food Safety Authority. Dietary reference values for vitamin D. <em>EFSA Journal</em>. 2016;14(10):4547.  </p>
<p style="text-align: justify;">(7) Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors. <em>Osteoporosis International</em>. 2016;27(4):1281–1386.  </p>
<p style="text-align: justify;">(8) Bonjour JP. Protein intake and bone health. <em>Int J Vitam Nutr Res</em>. 2011;81(2–3):134–142.  </p>
<p style="text-align: justify;">(9) Rizzoli R, Biver E, Brennan-Speranza TC, Bilezikian JP. Nutritional intake and bone health. <em>Lancet Diabetes Endocrinol</em>. 2021;9(9):606–621.  </p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/osteoporosis-and-nutrition-what-to-avoid-and-how-to-protect-your-bones/">Osteoporosis and Nutrition: What to Avoid and How to Protect Your Bones</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">31033</post-id>	</item>
		<item>
		<title>Hypertension in 2026: Preventing and Personalizing Cardiovascular Risk Management</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/hypertension-in-2026-preventing-and-personalizing-cardiovascular-risk-management/</link>
		
		<dc:creator><![CDATA[Dr. Martí]]></dc:creator>
		<pubDate>Tue, 10 Feb 2026 16:06:33 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[accelerated vascular aging]]></category>
		<category><![CDATA[arterial aging]]></category>
		<category><![CDATA[arterial stiffness]]></category>
		<category><![CDATA[cardiovascular risk]]></category>
		<category><![CDATA[envejecimiento]]></category>
		<category><![CDATA[heart attack]]></category>
		<category><![CDATA[high blood pressure]]></category>
		<category><![CDATA[ictus]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Sphygmocor]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/hypertension-in-2026-preventing-and-personalizing-cardiovascular-risk-management/</guid>

					<description><![CDATA[<p>Pulse wave velocity (PWV) is now the most accurate tool for the early detection of arterial aging and for understanding when hypertension truly begins—even when office blood pressure values are still within the normal range. Added to this is the value of the renin/aldosterone ratio, which allows us to identify the underlying mechanism driving blood [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/hypertension-in-2026-preventing-and-personalizing-cardiovascular-risk-management/">Hypertension in 2026: Preventing and Personalizing Cardiovascular Risk Management</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;"><strong>Pulse wave velocity (PWV) is now the most accurate tool for the early detection of arterial aging and for understanding when hypertension truly begins—even when office blood pressure values are still within the normal range. </strong></h1>
<p style="text-align: justify;"><strong>Added to this is the value of the renin/aldosterone ratio, which allows us to identify the underlying mechanism driving blood pressure elevation in each individual and to personalize management with unprecedented precision.</strong> <strong>This is what hypertension looks like in 2026: true anticipation and treatment tailored to each patient’s physiology.</strong></p>
<p style="text-align: justify;"><em> Dr. Carlos Martí – Neolife Medical Team</em></p>
<hr>
<p style="text-align: justify;"><strong>For years, hypertension was understood as a number: above 140/90 mmHg meant “disease”; below that threshold, “everything was fine.”</strong></p>
<p style="text-align: justify;">Today we know this approach is insufficient. The most recent evidence points to something more profound: elevated blood pressure is the late consequence of accelerated arterial aging—now recognized as vascular aging—which can be detected long before the blood pressure cuff shows abnormal values. </p>
<p style="text-align: justify;">What truly matters is no longer just measuring blood pressure, but understanding what is happening inside the arteries during that silent phase that determines future risk, even when everything appears normal. This represents one of the most important evolutions of recent years: <strong>hypertension</strong> is no longer seen solely as a diagnosis, but as an opportunity for early detection. A paradigm shift that reshapes how we assess <strong>cardiovascular risk</strong> and opens the door to earlier, more precise intervention with a real capacity for long-term prevention.  </p>
<p style="text-align: justify;">Over the past decade, we have learned that:</p>
<ul>
<li style="text-align: justify;">Vascular damage begins 5–10 years before blood pressure readings become elevated.</li>
<li style="text-align: justify;">Arterial stiffness predicts real cardiovascular risk more accurately than brachial blood pressure.</li>
<li style="text-align: justify;">Many individuals with “normal–high” blood pressure already show signs of arterial aging.</li>
</ul>
<p style="text-align: justify;">For this reason, the latest updates prioritize the assessment of vascular physiology rather than interpreting numbers alone.</p>
<p style="text-align: justify;"><strong>Arterial stiffness: the first “surname” of hypertension</strong></p>
<p style="text-align: justify;">One of the parameters that has gained the most relevance in recent years is <strong>pulse wave velocity (PWV</strong>), an essential marker of arterial stiffness. Understanding it is simple if we imagine our arteries as household pipes: when they are new, flexible, and well maintained, they absorb pressure and allow smooth flow. Over time, as they become stiffer, each pressure wave travels faster and with greater force.  </p>
<p style="text-align: justify;">PWV measures exactly how fast the pressure wave travels along the aorta.</p>
<p style="text-align: justify;">When this wave travels too quickly, the artery has lost elasticity. And this can occur years before blood pressure rises. In other words, a person may have “normal blood pressure” and yet already display the first surname of future hypertension: increased <strong>arterial stiffness</strong>, indicating premature vascular aging.  </p>
<p style="text-align: justify;"><strong>SphygmoCor: measuring what very few can</strong></p>
<p style="text-align: justify;">Assessing <strong>arterial stiffness</strong> cannot be done with a conventional blood pressure monitor. At Neolife, we use <strong>SphygmoCor</strong>, the international reference technology used in advanced cardiovascular research. </p>
<p style="text-align: justify;">This highly validated system allows us to:</p>
<ul>
<li style="text-align: justify;">Accurately measure <strong>PWV.</strong></li>
<li style="text-align: justify;">Calculate <strong>central blood pressure</strong>, which is the pressure that truly loads the heart and brain.</li>
<li style="text-align: justify;">Determine whether a patient’s arterial stiffness is appropriate for their age or reflects <strong>accelerated vascular aging</strong>.</li>
</ul>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Hipertension-1.png" alt="hypertension" width="1024" height="683"></p>
<p style="text-align: justify;">This technology, although widely validated, is still largely limited to centers with an advanced approach to vascular assessment. Its true value lies in its ability to detect alterations during <strong>the silent phase</strong>, when intervention is still both effective and highly personalized. </p>
<p style="text-align: justify;">This is the foundation of true prevention—not merely reactive care.</p>
<p style="text-align: justify;"><strong>RAAS and the renin/aldosterone ratio: the second surname of hypertension</strong></p>
<p style="text-align: justify;">In recent years—and particularly in the most recent updates—the <strong>renin/aldosterone ratio</strong> has gained greater importance, as it allows us to go beyond blood pressure values and understand the <strong>internal mechanism driving blood pressure elevation in each individual</strong><strong>.</strong></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Hipertension-2.png" alt="hypertension" width="1024" height="683"></p>
<p style="text-align: justify;"><strong>The RAAS (renin–angiotensin–aldosterone system)</strong> is the body’s mechanism for regulating blood pressure, salt balance, and fluid volume. It functions as an <strong>internal blood pressure thermostat</strong>: when the body perceives insufficient pressure or volume, it activates the system to raise it; when there is excess, it suppresses it. </p>
<ul>
<li style="text-align: justify;"><strong>Renin</strong> is the initial signal, released when the body detects low pressure or volume.</li>
<li>Renin triggers the formation of <strong>angiotensin,</strong> which <strong>constricts arteries </strong>and rapidly increases blood pressure.</li>
<li>Angiotensin then stimulates the release of <strong>aldosterone</strong><strong>,</strong> a hormone that promotes <strong>sodium and water retention</strong>, increasing circulating volume and sustaining elevated blood pressure.</li>
</ul>
<p style="text-align: justify;">By analyzing the<strong> renin/aldosterone ratio</strong>, we can identify <strong>which part of the system is altered—essentially</strong> determining the physiological mechanism pushing blood pressure upward in that specific individual. This is key to <strong>personalizing treatment</strong> and identifying the “second surname” of hypertension: whether there is excessive system activation, aldosterone predominance, or abnormally low renin levels. </p>
<p style="text-align: justify;">This approach allows us to move away from the uniform “<em>one-size-fits-all</em>” strategy. While some profiles clearly benefit from ACE <strong>inhibitors or angiotensin II receptor blockers (ARBs)</strong>, others respond better to <strong>calcium channel</strong> blockers, <strong>beta-blockers</strong>, <strong>aldosterone</strong> <strong>antagonists,</strong> or even <strong>targeted supplementation</strong> and <strong>lifestyle optimization strategies</strong><strong>.</strong></p>
<p style="text-align: justify;"><strong>Lifestyle in 2026: interventions that truly rejuvenate the vasculature</strong></p>
<p style="text-align: justify;">New guidelines emphasize something we know well at Neolife: not all lifestyle recommendations impact <strong>arterial health</strong> in the same way. Certain interventions directly improve arterial stiffness and central blood pressure. </p>
<p style="text-align: justify;">Resistance training combined with high-intensity intervals improves aortic elasticity more effectively than moderate exercise alone. Reducing visceral fat decreases hemodynamic load and improves central pressure.<br />Achieving deep, stable sleep—particularly restoring the normal “dipper” pattern—acts as a powerful nocturnal cardiovascular protector.<br />The dipper pattern refers to the natural nighttime reduction in blood pressure, typically around 10–20%. When this decline does not occur, cardiovascular risk increases significantly. It is assessed through 24-hour ambulatory blood pressure monitoring (ABPM), which tracks blood pressure behavior during sleep.     </p>
<p style="text-align: justify;">Importantly, these changes are not applied intuitively, but through a personalized approach: identifying the dominant mechanism in each individual and directing lifestyle interventions toward that specific target.</p>
<p style="text-align: justify;">Because <strong>hypertension</strong> is not prevented with generic advice, but by optimizing arterial physiology through precise and measurable interventions.</p>
<p style="text-align: justify;"><strong>The true antiaging approach: acting before disease appears</strong></p>
<p style="text-align: justify;">Traditional medicine diagnoses hypertension once blood pressure crosses a defined threshold. Longevity medicine prefers to intervene when physiology begins to deviate—before pathological numbers appear—helping the body return to its natural, physiological balance. </p>
<p style="text-align: justify;">If a patient already shows a first surname (increased arterial stiffness), a second surname (altered RAAS), or even rising central blood pressure, we are facing an early but still manageable process. This is the window of opportunity to get ahead of arterial aging and prevent long-term complications. </p>
<p style="text-align: justify;">That is the <strong>Neolife</strong> approach: anticipate, identify early changes, and act with precision to keep arterial health on its youngest possible trajectory.</p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p>(1) Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, Azizi M, Benetos A, Borghi C, Hitij JB, Cifkova R, Coca A, Cornelissen V, Cruickshank JK, Cunha PG, Danser AHJ, Pinho RM, Delles C, Dominiczak AF, Dorobantu M, Doumas M, Fernández-Alfonso MS, Halimi JM, Járai Z, Jelaković B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van de Borne P, Wanner C, Weber T, Williams B, Zhang ZY, Kjeldsen SE. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).  J Hypertens. 2023 Dec 1;41(12):1874-2071.</p>
<p>(2) McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912-4018.  </p>
<p>(3) Herzog MJ. Arterial stiffness and vascular aging: mechanisms, clinical implications, measurement and future perspectives. Signal Transduct Target Ther. 2025;10:23.   </p>
<p>(4) Adler, G. K., Brown, J. M., Vaidya, A., Calhoun, D. A., Carey, R. M., Funder, J. W., Stowasser, M., &amp; the Endocrine Society. (2025). Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. <em>Journal of Clinical Endocrinology &amp; Metabolism.</em> , ePub ahead of print.</p>
<p>(5) Manual MSD.</p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/hypertension-in-2026-preventing-and-personalizing-cardiovascular-risk-management/">Hypertension in 2026: Preventing and Personalizing Cardiovascular Risk Management</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">30301</post-id>	</item>
		<item>
		<title>“Silent Killer”: Understanding What Arterial Hypertension Is and Its Consequences (Part 2)</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/silent-killer-understanding-what-arterial-hypertension-is-and-its-consequences-part-2/</link>
		
		<dc:creator><![CDATA[Dra. Minguito]]></dc:creator>
		<pubDate>Fri, 30 Jan 2026 08:33:03 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[blood pressure]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[hormonas]]></category>
		<category><![CDATA[hypertension]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[risk factors]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/silent-killer-understanding-what-arterial-hypertension-is-and-its-consequences-part-2/</guid>

					<description><![CDATA[<p>You may not know that in Spain between one third and nearly half of adults have hypertension. This means that between 1 and 2 out of every 4 people suffer from high blood pressure, even though they may not be aware of it. You may also be unaware—or not fully conscious—that, much like diabetes mellitus, [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/silent-killer-understanding-what-arterial-hypertension-is-and-its-consequences-part-2/">“Silent Killer”: Understanding What Arterial Hypertension Is and Its Consequences (Part 2)</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1><strong>You may not know that in Spain between one third and nearly half of adults have hypertension. This means that between 1 and 2 out of every 4 people suffer from high blood pressure, even though they may not be aware of it. </strong></h1>
<p style="text-align: justify;">You may also be unaware—or not fully conscious—that, much like diabetes mellitus, arterial hypertension (HTN) is one of the main “silent killers” affecting our society. It often causes no symptoms, yet gradually damages our blood vessels and internal organs, increasing the risk of serious and potentially life-threatening complications. Every millimeter of mercury (the unit used to measure blood pressure) that is controlled represents time gained and health preserved. Would you like to understand why this is so?  </p>
<p style="text-align: justify;"><em> Dr. Minguito &#8211; Neolife Medical Team </em></p>
<hr>
<p style="text-align: justify;"><strong>Risk factors </strong></p>
<p style="text-align: justify;">In <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/asesino-silencioso-conozca-que-es-hipertension-arterial-y-sus-consecuencias-parte-1/">part 1</a> of this article, we discussed what hypertension is and its consequences. In this second part, we will review risk factors and pharmacological treatment. </p>
<p style="text-align: justify;">There are several risk factors that contribute to the development of arterial hypertension. Some cannot be changed, but others are within our control.</p>
<p><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">1. NON-MODIFIABLE RISK FACTORS</strong></p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Age</strong></li>
</ul>
<p style="text-align: justify;"><strong>Blood pressure</strong> tends to increase with age because blood vessels gradually lose elasticity, hormonal changes affect fluid and salt balance, and the cumulative effects of unhealthy habits build up over time. While approximately 5–10% of women aged 20–44 have hypertension, prevalence rises dramatically to 85% in women aged 75 or older (comparable figures for men are 10–15% and 80%, respectively). </p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HP1.jpg" alt="high blood pressure" width="1024" height="683"></p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Race</strong></li>
</ul>
<p style="text-align: justify;">High blood pressure affects people of all races, but African Americans have a significantly higher risk of developing hypertension. African American women, in particular, have higher rates than men from other racial groups. For this reason, African Americans should begin monitoring their blood pressure and adopting healthy habits from a young age. Other racial groups have similar risk levels, although Asian women tend to have a lower risk. Despite this, many Hispanic and Asian individuals with hypertension are unaware of their condition and remain untreated, highlighting the importance of blood pressure monitoring for everyone.   </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Family history and genetics</strong></li>
</ul>
<p style="text-align: justify;">Having parents or close relatives with <strong>hypertension</strong> increases your risk, as approximately 50% of blood pressure variability is hereditary. More than 800 genetic variants influence blood pressure; although each has a small effect individually, their cumulative impact can accelerate the development of hypertension with age. Therefore, genetic predisposition requires regular monitoring and awareness of family history. Nevertheless, healthy lifestyle habits can offset a large part of this risk.   </p>
<p><strong>2. MODIFIABLE RISK FACTORS </strong></p>
<p style="text-align: justify;">Lifestyle modifications often provide effective, non-pharmacological ways to control or reduce blood pressure, sometimes with results comparable to medication. A large proportion of hypertension cases are due to an unhealthy diet (and associated obesity), lack of exercise, excessive alcohol consumption, or a combination of these factors. </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Obesity</strong></li>
</ul>
<p style="text-align: justify;">One of the most effective lifestyle interventions for <strong>blood pressure</strong> control is weight loss. Excess body weight overloads the heart and promotes insulin resistance, both of which contribute to elevated blood pressure. Research shows a direct and consistent relationship between body mass index (BMI) and hypertension. Large studies suggest that obesity may account for 40–78% of hypertension cases.  </p>
<p style="text-align: justify;">Even modest weight loss can produce significant <strong>blood pressure</strong> reductions. A 2003 meta-analysis of 25 randomized clinical trials in overweight and obese adults found that for every kilogram of weight lost, systolic blood pressure decreased by approximately 1 mmHg and diastolic pressure by 0.92 mmHg. </p>
<p style="text-align: justify;"><strong>Weight loss</strong> can be achieved through caloric restriction, intermittent fasting, or dietary changes, and the best approach depends on what is most sustainable for each individual.</p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HP2.png" alt="high blood pressure" width="1024" height="683"></p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Dietary salt (sodium)</strong></li>
</ul>
<p style="text-align: justify;">The relationship between dietary sodium, <strong>hypertensio</strong>n risk, and overall <strong>health</strong> is complex. Some individuals and groups are more sensitive to the blood-pressure-raising effects of salt. These include African Americans, older adults, people with diabetes, chronic kidney disease, or pre-existing hypertension. For these groups, sodium intake should be reduced, ideally to 2,000 mg per day or less.<br />Although organizations such as the American Heart Association recommend even lower limits (1,500 mg/day), it is important to note that excessively low sodium intake can also cause problems. Studies have shown that very low sodium consumption may be associated with headaches, mental status changes, lethargy, cramps, nausea, dehydration, and excessively low blood pressure, increasing the risk of falls and injuries in older adults. Therefore, moderate sodium reduction is advised for low-risk individuals, with more aggressive reduction reserved for those who are salt-sensitive.      </p>
<p style="text-align: justify;">In addition to reducing sodium, increasing potassium intake—a mineral essential for muscle function, kidney health, and blood vessel relaxation—can help lower blood pressure. In hypertensive adults, potassium intake can reduce systolic pressure by 3–6 mmHg and diastolic pressure by 1–4 mmHg. The sodium-to-potassium ratio appears to be more important than absolute intake levels. Foods rich in potassium, such as bananas, potatoes, and legumes, are especially beneficial for individuals with high salt intake.    </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Exercise and blood pressure</strong></li>
</ul>
<p style="text-align: justify;">Aerobic exercise is highly effective. A meta-analysis of clinical trials lasting at least four weeks found that aerobic training can reduce systolic blood pressure by up to 8 mmHg and diastolic pressure by at least 5 mmHg. The optimal dose is 90–150 minutes per week at 65–75% of maximum heart rate (the so-called “Zone 2”). At Neolife, we recommend at least three hours per week.   </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Dynamic resistance training</strong></li>
</ul>
<p style="text-align: justify;">Strength training may temporarily raise blood pressure during exercise, but in the long term it reduces systolic pressure by about 2 mmHg and diastolic pressure by 3 mmHg, when performed for 90–150 minutes per week using weights ranging from 50–100% of one-repetition maximum. </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Isometric resistance training (no weights)</strong></li>
</ul>
<p style="text-align: justify;">This type of exercise has shown even greater reductions in systolic blood pressure—around 6 mmHg—and 3 mmHg in diastolic pressure, despite its seemingly low intensity.</p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Alcohol</strong></li>
</ul>
<p style="text-align: justify;">Current evidence shows that alcohol raises<strong> blood pressure</strong> in a dose-dependent manner. Genetic studies using Mendelian randomization confirm that even small amounts increase risk: each additional daily drink raises hypertension risk by 30%, and in heavy drinkers this risk can increase by up to 160%. There is no “safe” level of alcohol consumption for blood pressure. The good news is that reducing or stopping alcohol intake significantly lowers risk and improves cardiovascular health, even in former heavy drinkers.   </p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HP3.png" alt="high blood pressure" width="1024" height="683"></p>
<p><strong>3. OTHER FACTORS</strong></p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Sleep</strong></li>
</ul>
<p style="text-align: justify;">Poor sleep—whether due to insufficient or excessive duration, or disorders such as insomnia, snoring, or sleep apnea—is associated with a higher risk of <strong>hypertension</strong>. Evidence shows a U-shaped relationship, with increased risk below 7 hours and above 9 hours of sleep. Optimizing sleep quality is essential; <strong>up to half of hypertension cases could potentially be managed without medication through lifestyle changes alone.</strong>   </p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Stress</strong></li>
</ul>
<p style="text-align: justify;">Chronic <strong>stress</strong> is a major contributor to hypertension. Stress <strong>hormones</strong> such as cortisol increase heart rate and constrict blood vessels. Unhealthy coping mechanisms—overeating, smoking, or alcohol use—can further worsen blood pressure. Mindfulness, meditation, deep breathing, and physical activity are recommended strategies. Relaxation techniques and biofeedback have shown modest blood pressure reductions in some patients.    </p>
<ul>
<li style="text-align: justify;"><strong>Caffeine</strong></li>
</ul>
<p style="text-align: justify;">Caffeine can temporarily raise blood pressure, particularly in people who do not consume it regularly. However, habitual consumption does not appear to cause sustained hypertension or increase long-term risk.    </p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HP4.jpg" alt="high blood pressure" width="1024" height="683"></p>
<ul>
<li style="text-align: justify;"><strong style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';">Insulin resistance</strong></li>
</ul>
<p style="text-align: justify;"><strong>Insulin resistance</strong> and<strong> type 2 diabetes</strong> significantly impact blood pressure by reducing nitric oxide bioavailability, impairing vasodilation and increasing vascular resistance. </p>
<p style="text-align: justify;"><strong>Pharmacological treatment</strong></p>
<p style="text-align: justify;">As discussed, blood pressure control is a cornerstone in reducing cardiovascular disease, stroke, and kidney damage. Lifestyle modifications are the first-line approach, but when insufficient, pharmacological treatment becomes necessary.  </p>
<p style="text-align: justify;">Antihypertensive therapy must always be prescribed by a physician, who will select the most appropriate option based on individual characteristics and comorbidities. </p>
<p style="text-align: justify;">There are <strong>four main first-line drug</strong> classes:</p>
<ol>
<li style="text-align: justify;">Thiazide diuretics</li>
<li>Calcium channel blockers</li>
<li>Angiotensin-converting enzyme inhibitors (ACE inhibitors)</li>
<li>Angiotensin II receptor blockers (ARBs)</li>
</ol>
<p style="text-align: justify;">All typically reduce systolic <strong>blood pressure by 12–15 mmHg </strong>and <strong>diastolic pressure</strong> <strong>by 9–11 mmHg.</strong></p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HP-5.jpg" alt="high blood pressure" width="1024" height="683"></p>
<p style="text-align: justify;">ACE inhibitors, for example, can reduce blood pressure by up to 12.5/9.5 mmHg. It is recommended to initiate treatment at half of the maximum dose to minimize the risk of adverse effects. ARBs (angiotensin II receptor blockers) offer similar efficacy but with fewer side effects. In many cases, they are even considered superior, although ACE inhibitors tend to be less expensive because they have been on the market longer.   </p>
<p style="text-align: justify;">When ACE inhibitors cause cough—a common side effect—patients can be easily switched to an ARB. Thiazide diuretics and calcium channel blockers are also effective, achieving reductions of up to 15/10 mmHg, but they are more frequently associated with adverse effects. For this reason, they are often used as adjunctive therapy, once treatment with ACE inhibitors or ARBs has been optimized. As always, treatment decisions must be individualized.  </p>
<p style="text-align: justify;">This raises an important question: are there factors that determine which medication is best for a particular individual? The answer is yes. The optimal choice of antihypertensive therapy is patient-specific and depends on the presence of comorbid conditions and tolerance to potential side effects. For example, most calcium channel blockers are contraindicated in heart failure with reduced ejection fraction, and thiazide diuretics are generally considered less appropriate for patients with diabetes or prediabetes, as they may worsen metabolic parameters. ACE inhibitors and ARBs are contraindicated during pregnancy, although they are generally associated with fewer adverse effects than calcium channel blockers and thiazide diuretics.  </p>
<p style="text-align: justify;"><strong>Summary</strong></p>
<p style="text-align: justify;">It is important to emphasize that while medications are often more effective than any single lifestyle intervention, the combined effect of multiple lifestyle improvements can match the benefits of pharmacological therapy.</p>
<p style="text-align: justify;">At Neolife, we believe that blood pressure management is one of the most important pillars of longevity. It may not seem as glamorous as the latest anti-aging treatments, but it remains one of the most effective and well-established approaches in preventive medicine for reducing morbidity and mortality. </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) <strong>Banegas JR, Graciani A, López-García E, et al.</strong><br />
Prevalence, awareness, treatment and control of hypertension in Spain: results of a nationwide population-based study.<br />
<em>Rev Clin Esp (Barc).</em> 2024;224(2):83–92.<br />
Disponible en: PubMed.</p>
<p style="text-align: justify;">(2) <strong>Rodríguez-Roca GC, Coca A, Barrios V, et al.</strong><br />
Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España.<br />
<em>Hipertens Riesgo Vasc.</em> 2022;39(4):155–170.<br />
Disponible en: Elsevier.</p>
<p style="text-align: justify;">(3) <strong>Camafort M, Gijón-Conde T, Segura J, et al; IBERICAN Study Group.</strong><br />
Prevalence and control of hypertension in primary care: results from the IBERICAN study.<br />
<em>Eur J Gen Pract.</em> 2024;30(1):1–10.<br />
Disponible en: PMC.</p>
<p style="text-align: justify;">(4) <strong>Sociedad Española de Médicos de Atención Primaria (SEMERGEN).</strong><br />
Nota de prensa Día Mundial de la Hipertensión 2024.<br />
SEMERGEN; mayo 2024. Disponible en: SEMERGEN PDF. </p>
<p style="text-align: justify;">(5) <strong>Banegas JR, et al.</strong><br />
Prevalence of hypertension in Spain 2019: population-based nationwide study.<br />
<em>J Hypertens.</em> 2024;42(3):431–440.<br />
Disponible en: ScienceDirect.</p>
<p style="text-align: justify;">(6) <strong>SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, et al.</strong><br />
A randomized trial of intensive versus standard blood-pressure control.<br />
<em>N Engl J Med.</em> 2015;373(22):2103–2116.<br />
doi:10.1056/NEJMoa1511939</p>
<p style="text-align: justify;">(7) <strong>Zhang W, Zhang S, Deng Y, et al; STEP Study Group.</strong><br />
Trial of intensive blood-pressure control in older patients with hypertension.<br />
<em>N Engl J Med.</em> 2021;385(14):1268–1279.<br />
doi:10.1056/NEJMoa2111437</p>
<p style="text-align: justify;">(8) <strong>Whelton PK, Carey RM, Aronow WS, et al.</strong><br />
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.<br />
<em>J Am Coll Cardiol.</em> 2018;71(19):e127–e248.</p>
<p style="text-align: justify;">(9) <strong>Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM.</strong><br />
Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.<br />
2003;42(5):878–884.</p>
<p style="text-align: justify;">(10) <strong>He FJ, Li J, Macgregor GA.</strong><br />
Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.<br />
2013;346:f1325.</p>
<p style="text-align: justify;">(11) <strong>Huang L, Trieu K, Yoshimura S, et al.</strong><br />
Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials.<br />
2020;368:m315.</p>
<p style="text-align: justify;">(12) <strong>Brouillard AM, Kraja AT, Rich MW.</strong><br />
Trends in dietary sodium intake in the United States and the impact of USDA guidelines: NHANES 1999–2016.<br />
<em>Am J Med.</em> 2019;132(10):1199–1206.e5.</p>
<p style="text-align: justify;">(13) <strong>Cornelissen VA, Smart NA.</strong><br />
Exercise training for blood pressure: a systematic review and meta-analysis.<br />
<em>J Am Heart Assoc.</em> 2013;2(1):e004473.</p>
<p style="text-align: justify;">(14) <strong>Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K.</strong><br />
Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors.<br />
2003;290(23):3092–3100.</p>
<p style="text-align: justify;">(15) <strong>Kang DO, Lee DI, Roh SY, et al.</strong><br />
Reduced alcohol consumption and major adverse cardiovascular events among individuals with previously high alcohol consumption.<br />
<em>JAMA Netw Open.</em> 2024;7(3):e244013.</p>
<p style="text-align: justify;">(16) <strong>Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA.</strong><br />
Excessive alcohol consumption and hypertension: clinical implications of current research.<br />
<em>J Clin Hypertens (Greenwich).</em> 2005;7(6):346–351.</p>
<p style="text-align: justify;">(17) <strong>Han B, Chen WZ, Li YC, Chen J, Zeng ZQ.</strong><br />
Sleep and hypertension.<br />
<em>Sleep Breath.</em> 2020;24(1):351–356.</p>
<p style="text-align: justify;">(18) <strong>Li H, Ren Y, Wu Y, Zhao X.</strong><br />
Correlation between sleep duration and hypertension: a dose-response meta-analysis.<br />
<em>J Hum Hypertens.</em> 2019;33(3):218–228.</p>
<p style="text-align: justify;">(19) <strong>Agras WS.</strong><br />
Behavioral approaches to the treatment of essential hypertension.<br />
<em>Int J Obes.</em> 1981;5 Suppl 1:173–181.</p>
<p style="text-align: justify;">(20) <strong>Kennedy MD, Galloway AV, Dickau LJ, Hudson MK.</strong><br />
The cumulative effect of coffee and a mental stress task on heart rate, blood pressure, and mental alertness in caffeine-naïve and caffeine-habituated females.<br />
<em>Nutr Res.</em> 2008;28(9):609–614.</p>
<p style="text-align: justify;">(21) <strong>Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH.</strong><br />
The effect of coffee consumption on blood pressure and the development of hypertension.<br />
<em>J Hypertens.</em> 2012;30(12):2245–2254.</p>
<p style="text-align: justify;">(22) <strong>Kim JA, Montagnani M, Koh KK, Quon MJ.</strong><br />
Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.<br />
2006;113(15):1888–1904.</p>
<p style="text-align: justify;">(23) <strong>Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M.</strong><br />
Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies.<br />
<em>Med Clin (Barc).</em> 2005;124(16):606–12. doi:10.1157/13074389. </p>
<p style="text-align: justify;">(24) <strong>Tormo MJ, Navarro C, Chirlaque MD, Pérez-Flores D.</strong><br />
Prevalence and control of arterial hypertension in the South-East of Spain: a radical but still insufficient improvement.<br />
<em>Eur J Epidemiol.</em> 1997;13(3):301–8. doi:10.1023/A:1007341404633. </p>
<p style="text-align: justify;">(25) <strong>Gutiérrez-Misis A, Sánchez-Santos MT, Banegas JR, et al.</strong><br />
Prevalence and incidence of hypertension in a population cohort of people aged 65 years or older in Spain.<br />
<em>J Hypertens.</em> 2011;29(10):1863–70. doi:10.1097/HJH.0b013e32834ab497. </p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/silent-killer-understanding-what-arterial-hypertension-is-and-its-consequences-part-2/">“Silent Killer”: Understanding What Arterial Hypertension Is and Its Consequences (Part 2)</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">29956</post-id>	</item>
		<item>
		<title>“Silent Killer”: Learn What High Blood Pressure Is and Its Consequences (Part 1)</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/asesino-silencioso-conozca-que-es-hipertension-arterial-y-sus-consecuencias-parte-1/</link>
		
		<dc:creator><![CDATA[Dra. Minguito]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 12:26:37 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[blood pressure]]></category>
		<category><![CDATA[cardiovascular events]]></category>
		<category><![CDATA[cardiovascular health]]></category>
		<category><![CDATA[cardiovascular mortality]]></category>
		<category><![CDATA[cardiovascular risks]]></category>
		<category><![CDATA[diastole]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[high blood pressure]]></category>
		<category><![CDATA[secondary hypertension]]></category>
		<category><![CDATA[stress]]></category>
		<category><![CDATA[systemic or peripheral circulation]]></category>
		<category><![CDATA[systole]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/asesino-silencioso-conozca-que-es-hipertension-arterial-y-sus-consecuencias-parte-1/</guid>

					<description><![CDATA[<p>May not know that in Spain, between one third and nearly half of adults have hypertension. This means that between 1 and 2 out of every 4 people have high blood pressure—although they may not always be aware of it. And may also not know, or may not be fully aware, that—much like diabetes mellitus—arterial [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/asesino-silencioso-conozca-que-es-hipertension-arterial-y-sus-consecuencias-parte-1/">“Silent Killer”: Learn What High Blood Pressure Is and Its Consequences (Part 1)</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr />
<h1 style="text-align: justify;">May not know that in Spain, <strong>between one third and nearly half of adults </strong>have hypertension. This means that <strong>between 1 and 2 out of every 4 people </strong>have high blood pressure—although they may not always be aware of it.</h1>
<p style="text-align: justify;">And may also not know, or may not be fully aware, that—much like diabetes mellitus—arterial hypertension (HTN) is one of the main “silent killers” affecting our society. It often causes no symptoms, yet it gradually damages our blood vessels and internal organs, increasing the risk of serious and potentially fatal complications. Every millimeter of mercury (the unit used to measure blood pressure) that is brought under control represents time gained and health preserved. Would you like to learn why this is so?</p>
<p style="text-align: justify;"><em> Dr. Minguito &#8211; Neolife Medical Team</em></p>
<hr />
<p style="text-align: justify;"><strong>What Is Arterial Hypertension?</strong></p>
<p style="text-align: justify;"><strong>Arterial hypertension</strong> is one of the leading <strong>cardiovascular risk</strong> factors in our society. At Neolife, we aim to provide you with a clear perspective so you can understand what it is, why it is so important to keep it well controlled, and what poor control can lead to. Here’s a spoiler: <u>if you care about your brain, your heart, and your kidneys, you need low blood pressure.</u></p>
<p style="text-align: justify;">When we talk about <strong>blood pressure</strong>, we are referring to the force exerted by the blood against the walls of the arteries as the heart beats. We have all heard, during a doctor’s visit, two measurements: the “upper” and the “lower” numbers—but what do they actually mean?</p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NL-presion-arterial-0.jpg" alt="blood pressure" width="1024" height="683" /></p>
<p style="text-align: justify;">The cardiac cycle has two main phases: systole and diastole. During systole, the heart’s ventricles (the lower chambers) contract to eject blood. The left ventricle is especially important in this process because it is more muscular than the right and is responsible for pumping blood throughout the body, overcoming the resistance of the peripheral circulatory system.<br />
It is worth noting that here we are referring to systemic or peripheral circulation—the circulation that supplies the body in general—and not to pulmonary pressure, which is a different measurement. Blood pressure, commonly reported as “120 over 80,” refers to pressure in the peripheral circulation. Pulmonary pressure, which is mainly regulated by the right ventricle, is considerably lower.</p>
<p style="text-align: justify;">During systole, the left ventricle contracts and pushes blood out of the heart through the aortic valve into the aorta (the large artery leaving the heart), from where it is rapidly distributed throughout the body. In this phase, the blood exerts pressure against the arterial walls—this is the systolic pressure (the “upper” number).</p>
<p style="text-align: justify;">The second phase of the cycle is <strong>diastole</strong>, which is equally important. During diastole, the heart relaxes after ejecting blood, allowing the ventricles to fill again from the atria. This is also the phase during which the heart itself receives its blood supply through the coronary arteries. Although blood pressure is lower during diastole, there is still a constant or tonic pressure within the arteries—this is the diastolic pressure (the “lower” number).</p>
<p style="text-align: justify;"><strong>What Does It Mean to Have High Blood Pressure, and Why Is It So Important to Keep It at Optimal Levels?</strong></p>
<p style="text-align: justify;">Since 2017, guidelines have changed following the publication of the SPRINT clinical trial (Systolic Blood Pressure Intervention Trial) in 2015. Current recommendations, in effect for approximately six years, establish new blood pressure categories.</p>
<p style="text-align: center;"><strong>Blood pressure classification (according to current guidelines)</strong></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NL-presion-arterial-2.png" alt="blood pressure" width="1024" height="683" /></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NL-presion-arterial-1.png" alt="blood pressure" width="1024" height="683" /></p>
<p style="text-align: justify;">For example, a person with a blood pressure of 120/83 mmHg would already fall into the category of stage 1 hypertension, even though their systolic pressure remains within the traditionally “normal” range.</p>
<p style="text-align: justify;"><strong>Where Do These Values Come From? The SPRINT Trial (2015)</strong></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NL-presion-arterial-3.jpg" alt="blood pressure" width="1024" height="683" /></p>
<p style="text-align: justify;">The aim of the SPRINT study was to evaluate the benefits of intensive blood pressure control. Nearly 10,000 individuals with a systolic blood pressure of 130 mmHg or higher and a high cardiovascular risk—but without type 2 diabetes—were included. This population was selected because a higher probability of cardiovascular events over a short period was expected, making it easier to assess clinical outcomes.</p>
<p style="text-align: justify;">Participants were randomly assigned to two groups:</p>
<ul>
<li style="text-align: justify;"><strong>Intensive treatment</strong>: target <strong>systolic blood pressure below 120 mmHg.</strong></li>
<li><strong>Standard treatment:</strong> target systolic blood pressure below 140 mmHg.</li>
</ul>
<p style="text-align: justify;">At baseline, the average blood pressure of participants was approximately 140/78 mmHg. After one year of treatment, average systolic blood pressure was 121.4 mmHg in the intensive-treatment group and 136.2 mmHg in the standard-treatment group.</p>
<p style="text-align: justify;">The most striking aspect of the study was that it was stopped early due to the clear clinical benefits observed in the intensive-treatment group. The most notable finding was a reduction in all-cause mortality—not only from cardiovascular causes, but also from kidney disease, accidents, suicides, and even homicides. This benefit was unexpected and surprised many experts.</p>
<p style="text-align: justify;">This study was one of the most compelling demonstrations that intensively controlling systolic blood pressure below 120 mmHg can save lives and reduce cardiovascular events, even over a relatively short period.</p>
<p style="text-align: justify;">The study also reminds us that conditions such as hypertension, smoking, and elevated apoB levels (a marker of atherogenic cholesterol) cause cumulative damage over time. Hypertension mechanically damages the vascular endothelium, smoking causes chemical damage to the same tissue, and LDL cholesterol (which contains apoB) infiltrates the damaged endothelium, initiating the atherosclerotic cascade. For this reason, early reduction of all these risk factors has an enormous cumulative effect over time.</p>
<p style="text-align: justify;">Years later, in 2021, the STEP study in China once again demonstrated that strict blood pressure control reduces <strong>cardiovascular events</strong> and <strong>cardiovascular mortality.</strong></p>
<p style="text-align: justify;">We may still hear—or hold on to—the outdated belief that a blood pressure of 140/90 mmHg is acceptable. However, in light of all this evidence, it is clear that this is not the case. We need to change our mindset and pursue intensive control, aiming for a target of approximately 120/80 mmHg.</p>
<p style="text-align: justify;">As early as the 1960s, the first data from the Framingham Heart Study had already shown the harmful effects of elevated blood pressure (at that time, hypertension was defined as any value above 140/90 mmHg). Lowering blood pressure from levels above that threshold already demonstrated clear benefits.</p>
<p style="text-align: justify;">More recently, other meta-analyses have confirmed these findings. In individuals aged 40 to 70, for every 20 mmHg increase in <strong>systolic pressure </strong>or 10 mmHg increase in diastolic pressure, the risk of death from heart attack, stroke, or <strong>vascular disease</strong> doubles. This refers not only to a higher incidence of disease, but to a higher probability of death. For example, having a blood pressure of 140/90 instead of 120/80 doubles the risk of vascular death.</p>
<p style="text-align: justify;"><strong>Other Organs Affected</strong></p>
<p style="text-align: justify;">The heart is not the only organ sensitive to hypertension. The brain is particularly vulnerable to <strong>high</strong> <strong>blood pressure</strong>, as both depend on proper perfusion through small vessels. Hypertension exerts a mechanical force that damages these vessels, increasing the risk of stroke and dementia.</p>
<p style="text-align: justify;">The SPRINT-MIND trial, a substudy of SPRINT focused on cognitive decline, evaluated whether intensive treatment could prevent dementia. With more than 9,000 participants, the results showed an absolute reduction in dementia risk of 0.6% and a relative reduction of 16%. Thus, controlling blood pressure protects the brain.</p>
<p style="text-align: justify;">The kidneys are another organ extremely sensitive to elevated blood pressure. Despite accounting for only 1–2% of body weight, they receive 20–25% of cardiac output (the amount of blood the heart pumps each minute to deliver oxygen and nutrients throughout the body). This implies a highly specialized and vulnerable vascular network. Hypertension accelerates the decline in glomerular filtration rate (GFR), reducing kidney function.<br />
The situation worsens when elevated glucose levels are also present—a common combination, for example, in metabolic syndrome (which includes hypertension and insulin resistance). This leads to a progressive and dangerous decline in kidney function, often undetected if only creatinine is measured. For this reason, at Neolife, when kidney function impairment is suspected, we use cystatin C, a more sensitive marker.</p>
<p style="text-align: justify;">The key message from these studies is that lowering blood pressure—even in individuals already diagnosed with hypertension—can significantly reduce the risk of <strong>heart disease</strong>, <strong>stroke</strong>, and other serious <strong>health</strong> conditions. While preventing blood pressure elevation in the first place is ideal, these trials show that reducing blood pressure after it has already exceeded optimal ranges still offers enormous <strong>cardiovascular benefits</strong>.</p>
<p style="text-align: justify;"><strong>Caution: Low Blood Pressure, but Not Too Low </strong></p>
<p style="text-align: justify;">While high blood pressure is dangerous, excessively low blood pressure can also cause problems—although in this case, symptoms matter more than numbers. Technically, low blood pressure is defined as below 90/60 mmHg, but what truly matters is how the person feels.</p>
<p style="text-align: justify;">Common symptoms of <strong>low blood pressure </strong>include dizziness, lightheadedness, nausea, fainting or syncope, dehydration or excessive thirst, difficulty concentrating, blurred vision, cold and pale skin, rapid and shallow breathing, and fatigue.</p>
<p style="text-align: justify;">Not everyone with low blood pressure experiences symptoms. Some people may feel perfectly well with readings such as 100/70 mmHg, while others may not tolerate these levels, especially if they have lost weight or are taking antihypertensive medications.</p>
<p style="text-align: justify;">For this reason, <strong>blood pressure</strong> management requires a personalized approach. As weight is lost, exercise increases, or other factors change, blood pressure may decrease naturally, and medications must be carefully adjusted to avoid adverse effects such as fainting or loss of balance.</p>
<p style="text-align: justify;"><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/NL-presion-arterial-4.jpg" alt="blood pressure" width="1024" height="683" /></p>
<p style="text-align: justify;"><strong>Blood Pressure Variations Throughout the Day and With Exercise</strong></p>
<p style="text-align: justify;">Blood pressure naturally fluctuates throughout the day. A key observation is that during the night, it should decrease by 10–20% compared to daytime values. This is partly due to the horizontal position during sleep, which reduces the effort the heart needs to send blood to the brain. Additionally, sympathetic tone (the body’s “alert” system) should decrease at night, while parasympathetic tone—especially vagal activity—increases, promoting relaxation. Continuous blood pressure monitoring seeks precisely this nocturnal dip as a marker of <strong>cardiovascular health.</strong></p>
<p style="text-align: justify;"><strong>Stress</strong> also plays an important role. Transient stressful events can significantly raise blood pressure. Leaving excess cortisol (hypercortisolemia) uncontrolled can be just as harmful as persistent hypertension.</p>
<p style="text-align: justify;">It is completely normal for systolic blood pressure to rise during exercise, as the heart needs to pump more blood to deliver oxygen to the muscles. In contrast, diastolic pressure usually remains stable or decreases slightly. This occurs because, during exercise, blood vessels in the muscles dilate (vasodilation), reducing resistance in the circulation. Thanks to this mechanism, exercise acts as a natural regulator of blood pressure: it improves arterial elasticity, reduces vascular resistance, and over time helps control resting blood pressure.</p>
<p style="text-align: justify;"><strong>Primary vs. Secondary Hypertension</strong></p>
<p style="text-align: justify;">Another important concept is that hypertension may be due to an identifiable cause—this is known as <strong>secondary hypertension</strong>. It is caused by an underlying medical condition that may potentially be corrected. It is estimated that about 10% of hypertension cases have a secondary cause, so it is important not to assume that all hypertension is “essential” or primary.</p>
<p style="text-align: justify;">There are warning signs that suggest secondary hypertension, such as lack of response to medications, loss of response to previously effective treatments, extremely high blood pressure (above 180 mmHg), or sudden onset. It is also suspicious when a young person with no family history or risk factors develops high blood pressure.</p>
<p style="text-align: justify;">Other secondary causes that should not be overlooked include kidney disease, renal artery stenosis, thyroid disorders, sleep apnea, and hyperaldosteronism (which may result from prolonged corticosteroid use or adrenal gland disorders), among others.</p>
<p>At Neolife, we believe that blood pressure management is one of the most important pillars of longevity. It may not sound as glamorous as the latest anti-aging treatments, but it is one of the <strong>most effective and well-proven</strong> strategies in preventive medicine to reduce morbidity and mortality.</p>
<hr />
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) <strong>Banegas JR, Graciani A, López-García E, et al.</strong><br />
Prevalence, awareness, treatment and control of hypertension in Spain: results of a nationwide population-based study.<br />
<em>Rev Clin Esp (Barc).</em> 2024;224(2):83–92.<br />
Disponible en: PubMed.</p>
<p style="text-align: justify;">(2) <strong>Rodríguez-Roca GC, Coca A, Barrios V, et al.</strong><br />
Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España.<br />
<em>Hipertens Riesgo Vasc.</em> 2022;39(4):155–170.<br />
Disponible en: Elsevier.</p>
<p style="text-align: justify;">(3) <strong>Camafort M, Gijón-Conde T, Segura J, et al; IBERICAN Study Group.</strong><br />
Prevalence and control of hypertension in primary care: results from the IBERICAN study.<br />
<em>Eur J Gen Pract.</em> 2024;30(1):1–10.<br />
Disponible en: PMC.</p>
<p style="text-align: justify;">(4) <strong>Sociedad Española de Médicos de Atención Primaria (SEMERGEN).</strong><br />
Nota de prensa Día Mundial de la Hipertensión 2024.<br />
SEMERGEN; mayo 2024. Disponible en: SEMERGEN PDF.</p>
<p style="text-align: justify;">(5) <strong>Banegas JR, et al.</strong><br />
Prevalence of hypertension in Spain 2019: population-based nationwide study.<br />
<em>J Hypertens.</em> 2024;42(3):431–440.<br />
Disponible en: ScienceDirect.</p>
<p style="text-align: justify;">(6) <strong>SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, et al.</strong><br />
A randomized trial of intensive versus standard blood-pressure control.<br />
<em>N Engl J Med.</em> 2015;373(22):2103–2116.<br />
doi:10.1056/NEJMoa1511939</p>
<p style="text-align: justify;">(7) <strong>Zhang W, Zhang S, Deng Y, et al; STEP Study Group.</strong><br />
Trial of intensive blood-pressure control in older patients with hypertension.<br />
<em>N Engl J Med.</em> 2021;385(14):1268–1279.<br />
doi:10.1056/NEJMoa2111437</p>
<p style="text-align: justify;">(8) <strong>Whelton PK, Carey RM, Aronow WS, et al.</strong><br />
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.<br />
<em>J Am Coll Cardiol.</em> 2018;71(19):e127–e248.</p>
<p style="text-align: justify;">(9) <strong>Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM.</strong><br />
Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.<br />
2003;42(5):878–884.</p>
<p style="text-align: justify;">(10) <strong>He FJ, Li J, Macgregor GA.</strong><br />
Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.<br />
2013;346:f1325.</p>
<p style="text-align: justify;">(11) <strong>Huang L, Trieu K, Yoshimura S, et al.</strong><br />
Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials.<br />
2020;368:m315.</p>
<p style="text-align: justify;">(12) <strong>Brouillard AM, Kraja AT, Rich MW.</strong><br />
Trends in dietary sodium intake in the United States and the impact of USDA guidelines: NHANES 1999–2016.<br />
<em>Am J Med.</em> 2019;132(10):1199–1206.e5.</p>
<p style="text-align: justify;">(13) <strong>Cornelissen VA, Smart NA.</strong><br />
Exercise training for blood pressure: a systematic review and meta-analysis.<br />
<em>J Am Heart Assoc.</em> 2013;2(1):e004473.</p>
<p style="text-align: justify;">(14) <strong>Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K.</strong><br />
Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors.<br />
2003;290(23):3092–3100.</p>
<p style="text-align: justify;">(15) <strong>Kang DO, Lee DI, Roh SY, et al.</strong><br />
Reduced alcohol consumption and major adverse cardiovascular events among individuals with previously high alcohol consumption.<br />
<em>JAMA Netw Open.</em> 2024;7(3):e244013.</p>
<p style="text-align: justify;">(16) <strong>Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA.</strong><br />
Excessive alcohol consumption and hypertension: clinical implications of current research.<br />
<em>J Clin Hypertens (Greenwich).</em> 2005;7(6):346–351.</p>
<p style="text-align: justify;">(17) <strong>Han B, Chen WZ, Li YC, Chen J, Zeng ZQ.</strong><br />
Sleep and hypertension.<br />
<em>Sleep Breath.</em> 2020;24(1):351–356.</p>
<p style="text-align: justify;">(18) <strong>Li H, Ren Y, Wu Y, Zhao X.</strong><br />
Correlation between sleep duration and hypertension: a dose-response meta-analysis.<br />
<em>J Hum Hypertens.</em> 2019;33(3):218–228.</p>
<p style="text-align: justify;">(19) <strong>Agras WS.</strong><br />
Behavioral approaches to the treatment of essential hypertension.<br />
<em>Int J Obes.</em> 1981;5 Suppl 1:173–181.</p>
<p style="text-align: justify;">(20) <strong>Kennedy MD, Galloway AV, Dickau LJ, Hudson MK.</strong><br />
The cumulative effect of coffee and a mental stress task on heart rate, blood pressure, and mental alertness in caffeine-naïve and caffeine-habituated females.<br />
<em>Nutr Res.</em> 2008;28(9):609–614.</p>
<p style="text-align: justify;">(21) <strong>Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH.</strong><br />
The effect of coffee consumption on blood pressure and the development of hypertension.<br />
<em>J Hypertens.</em> 2012;30(12):2245–2254.</p>
<p style="text-align: justify;">(22) <strong>Kim JA, Montagnani M, Koh KK, Quon MJ.</strong><br />
Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.<br />
2006;113(15):1888–1904.</p>
<p style="text-align: justify;">(23) <strong>Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M.</strong><br />
Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies.<br />
<em>Med Clin (Barc).</em> 2005;124(16):606–12. doi:10.1157/13074389.</p>
<p style="text-align: justify;">(24) <strong>Tormo MJ, Navarro C, Chirlaque MD, Pérez-Flores D.</strong><br />
Prevalence and control of arterial hypertension in the South-East of Spain: a radical but still insufficient improvement.<br />
<em>Eur J Epidemiol.</em> 1997;13(3):301–8. doi:10.1023/A:1007341404633.</p>
<p style="text-align: justify;">(25) <strong>Gutiérrez-Misis A, Sánchez-Santos MT, Banegas JR, et al.</strong><br />
Prevalence and incidence of hypertension in a population cohort of people aged 65 years or older in Spain.<br />
<em>J Hypertens.</em> 2011;29(10):1863–70. doi:10.1097/HJH.0b013e32834ab497.</p>
<hr />
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/asesino-silencioso-conozca-que-es-hipertension-arterial-y-sus-consecuencias-parte-1/">“Silent Killer”: Learn What High Blood Pressure Is and Its Consequences (Part 1)</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">29879</post-id>	</item>
		<item>
		<title>The power of oral hyaluronic acid: hydration, youthfulness, and mobility from within</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/the-power-of-oral-hyaluronic-acid-hydration-youthfulness-and-mobility-from-within/</link>
		
		<dc:creator><![CDATA[Dr. Galán]]></dc:creator>
		<pubDate>Mon, 01 Dec 2025 10:51:25 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[cartilage]]></category>
		<category><![CDATA[collagen]]></category>
		<category><![CDATA[Elastin. Hormonal Optimization Therapy]]></category>
		<category><![CDATA[envejecimiento]]></category>
		<category><![CDATA[fibroblast]]></category>
		<category><![CDATA[fur]]></category>
		<category><![CDATA[hyaluronic acid]]></category>
		<category><![CDATA[NeoHyaluronic]]></category>
		<category><![CDATA[osteoarthritis]]></category>
		<category><![CDATA[wrinkles]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/?p=29404</guid>

					<description><![CDATA[<p>In a clinical trial in women aged 45 to 60, 120 mg/day of hyaluronic acid significantly improved dermal hydration and elasticity after 12 weeks compared to the placebo group. The deterioration of Skin and joints share the progressive loss of collagen, elastin, and hyaluronic acid in our tissues. These substances not only provide support and [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/the-power-of-oral-hyaluronic-acid-hydration-youthfulness-and-mobility-from-within/">The power of oral hyaluronic acid: hydration, youthfulness, and mobility from within</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr />
<h1 style="text-align: justify;"><strong>In a clinical trial in women aged 45 to 60, 120 mg/day of hyaluronic acid significantly improved dermal hydration and elasticity after 12 weeks compared to the placebo group.</strong></h1>
<p style="text-align: justify;"><em>The deterioration of </em><em>Skin and joints share the progressive loss of collagen, elastin, and hyaluronic acid in our tissues. These substances not only provide support and elasticity to the skin, but are also essential for maintaining the function of our joints. </em></p>
<p style="text-align: justify;"><em> Dr. Alfonso Galán – Neolife Medical Team</em></p>
<hr />
<p style="text-align: justify;"><strong>One of the most promising strategies, with the strongest scientific backing, is oral hyaluronic acid supplementation, both for skin care and for joint health.</strong></p>
<p style="text-align: justify;">As we <strong>age</strong>, two of the most frequent complaints among men and women are the appearance of wrinkles, loss of firmness and radiance in the skin, and the onset of joint discomfort, stiffness, or even the first signs of osteoarthritis.</p>
<p style="text-align: justify;">Although these processes are natural, they share a structural cause: the gradual decline of <strong>collagen</strong>, <strong>elastin</strong>, and <strong>hyaluronic</strong> acid in our tissues. These substances not only provide support and elasticity to the skin, but are also essential for maintaining the cushioning function of our joints.</p>
<p style="text-align: justify;">The good news is that today we know we can act from within, with safe and effective interventions that help reverse or slow down these changes.</p>
<p style="text-align: justify;">One of the most promising and best-supported interventions is <strong>oral hyaluronic acid supplementation</strong>, both for skin care and joint health.</p>
<p style="text-align: justify;"><strong>Skin hydration</strong><strong> and firmness from within</strong></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/AH.png" alt="hyaluronic acid" width="1024" height="683" /></p>
<p style="text-align: justify;"><span lang="ES-TRAD">As <b>we age</b>, the <strong>hyaluronic acid (HA)</strong> content in our skin decreases dramatically. This contributes to loss of volume, elasticity, and firmness, and to the formation of wrinkles. </span></p>
<p style="text-align: justify;"><span lang="ES-TRAD">Double-blind, placebo-controlled clinical studies</span> <span lang="ES-TRAD">have shown that oral hyaluronic acid supplementation:</span></p>
<ul style="text-align: justify;">
<li style="text-align: justify;">Significantly increases <strong>dermal hydration</strong> (up to +28% in 6–12 weeks)</li>
<li>Reduces <strong>wrinkle depth</strong> by 10% to 20%</li>
<li>Improves <strong>skin elasticity</strong> and overall texture</li>
<li>Enhances <strong>fibroblast</strong> activity, stimulating the production of collagen and elastin</li>
</ul>
<p style="text-align: justify;"><span lang="ES-TRAD">In a clinical trial in women aged 45 to 60, 120 mg/day of hyaluronic acid significantly improved dermal hydration and elasticity after 12 weeks compared to placebo.</span></p>
<p style="text-align: justify;"><strong>Protected joints, restored movement</strong></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/AH-2.jpg" alt="hyaluronic acid" width="1024" height="683" /></p>
<p><span lang="ES-TRAD"><b>Hyaluronic acid</b> is also a natural component of synovial fluid and joint cartilage, where it acts as a <strong>“natural</strong><b> lubricant.”</b></span></p>
<p><span lang="ES-TRAD">In patients with <strong>mild to moderate osteoarthritis</strong><b>, </b>multiple clinical trials have shown that oral hyaluronic acid:</span></p>
<ul>
<li><strong>Reduces joint pain</strong> (significant improvements on the WOMAC scale of osteoarthritis-related disability)</li>
<li>Improves <strong>mobility</strong> and joint function</li>
<li>Increases <strong>collagen and proteoglycan</strong> content in cartilage</li>
<li>Reduces the need for anti-inflammatory medications in chronic joint degeneration</li>
</ul>
<p><span lang="ES-TRAD">Effective doses used in studies range between <strong>80 and 200 mg daily</strong>, with visible improvements in 8–12 weeks.</span></p>
<p><strong>How does oral hyaluronic acid work?</strong></p>
<p><span lang="ES-TRAD">Although for many years it was thought that <b>hyaluronic acid</b> had to be injected to be effective, we now know that:</span></p>
<ul>
<li style="text-align: justify;">Oral hyaluronic acid is <strong>broken down in the intestine</strong> into bioactive units.</li>
<li>These units are absorbed and stimulate <strong>CD44</strong> receptors, inducing the synthesis of more endogenous hyaluronic acid and collagen.</li>
<li><strong>Increases in hyaluronic acid</strong> content in the dermis and cartilage have been documented after oral supplementation.</li>
</ul>
<p><strong>Powerful synergies</strong></p>
<p style="text-align: justify;"><span lang="ES-TRAD">At <b>Neolife,</b> we recommend combining hyaluronic acid with other active ingredients that reinforce its action.</span></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/AH-3.png" alt="hyaluronic acid" width="1024" height="683" /></p>
<p style="text-align: justify;"><span lang="ES-TRAD">This combination has shown greater clinical and functional efficacy in studies than hyaluronic acid alone.</span></p>
<p style="text-align: justify;"><span lang="ES-TRAD">Moreover, as we discussed in <a href="https://www.neolifesalud.com/en/?p=28536">another article on our blog</a>, it has a wonderful synergy with <b>Hormone Optimization Therapy</b>.</span></p>
<p style="text-align: justify;"><strong>What do the studies say?</strong></p>
<p style="text-align: justify;"><span lang="ES-TRAD">Recent systematic reviews and meta-analyses</span> <span lang="ES-TRAD">conclude that:</span></p>
<ul>
<li style="text-align: justify;"><strong>Oral hyaluronic acid</strong> <strong>increases skin hydration and elasticity </strong>compared to placebo.</li>
<li>Reduces joint pain in knee and hand osteoarthritis.</li>
<li>Improves quality of life and function in active older adults.</li>
<li>Shows <strong>excellent tolerance and safety</strong> in the medium and long term.</li>
</ul>
<p style="text-align: justify;"><strong>Conclusion </strong></p>
<p style="text-align: justify;"><span lang="ES-TRAD">Science supports the use of <strong>oral hyaluronic acid</strong> as an effective and safe intervention for:</span></p>
<ul>
<li style="text-align: justify;">Care for your skin from within</li>
<li>Prevent and improve joint wear</li>
<li>Maintain functional youth for longer</li>
</ul>
<p style="text-align: justify;"><span lang="ES-TRAD">Just one capsule a day can make a meaningful difference in your skin and joint health.</span><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/HA-NL-2.png" alt="hyaluronic acid" width="1024" height="683" /></p>
<hr />
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) Fukui T, et al. <em>The effect of hyaluronic acid ingestion on dry skin: a double-blind, placebo-controlled study.</em> Clin Cosmet Investig Dermatol. 2017;10:267–273.</p>
<p style="text-align: justify;">(2) Kalman DS, et al. <em>Effect of a natural extract of chicken combs with a high content of hyaluronic acid on pain relief and quality of life in subjects with knee osteoarthritis.</em> Nutr J. 2008;7:3.</p>
<p style="text-align: justify;">(3) Oe M, et al. <em>Oral hyaluronan relieves knee pain: A review.</em> 2021;13(1):223.</p>
<p style="text-align: justify;">(4) Sato H, et al. <em>Clinical effects of hyaluronic acid on dry skin.</em> J New Rem Clin. 2002;51:548–556.</p>
<p style="text-align: justify;">(5) DuRaine GD, et al. <em>Evaluation of oral hyaluronan for osteoarthritis symptom relief: A meta-analysis.</em> Int J Rheum Dis. 2020;23(5):560–568.</p>
<hr />
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/the-power-of-oral-hyaluronic-acid-hydration-youthfulness-and-mobility-from-within/">The power of oral hyaluronic acid: hydration, youthfulness, and mobility from within</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">29404</post-id>	</item>
		<item>
		<title>Small Doses, Big Effects: GLP-1 and Longevity</title>
		<link>https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/small-doses-big-effects-glp-1-and-longevity/</link>
		
		<dc:creator><![CDATA[Dra. Sánchez]]></dc:creator>
		<pubDate>Wed, 30 Jul 2025 06:43:34 +0000</pubDate>
				<category><![CDATA[Prevention and Anti-aging]]></category>
		<category><![CDATA[age]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[anti-aging]]></category>
		<category><![CDATA[brain health]]></category>
		<category><![CDATA[cardioprotection]]></category>
		<category><![CDATA[cardiovascular disease]]></category>
		<category><![CDATA[cardiovascular diseases]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[envejecimiento]]></category>
		<category><![CDATA[GLP-1 receptor agonists]]></category>
		<category><![CDATA[inflamación]]></category>
		<category><![CDATA[mitochondria]]></category>
		<category><![CDATA[neuroprotection]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[Semaglutide]]></category>
		<category><![CDATA[tirzepatide]]></category>
		<category><![CDATA[visceral fat]]></category>
		<guid isPermaLink="false">https://www.neolifesalud.com/blog/uncategorized/small-doses-big-effects-glp-1-and-longevity/</guid>

					<description><![CDATA[<p>You’ve probably heard of medications like Ozempic, Wegovy, or Mounjaro, which are primarily used for weight loss or blood sugar control in people with diabetes. But did you know that these therapies might be opening new doors in the field of longevity? We’d like to share how these small weekly injections can have powerful effects [&#8230;]</p>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/small-doses-big-effects-glp-1-and-longevity/">Small Doses, Big Effects: GLP-1 and Longevity</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></description>
										<content:encoded><![CDATA[<hr>
<h1 style="text-align: justify;">You’ve probably heard of medications like Ozempic, Wegovy, or Mounjaro, which are primarily used for weight loss or blood sugar control in people with diabetes.</h1>
<p style="text-align: justify;">But did you know that these therapies might be opening new doors in the field of longevity? We’d like to share how these small weekly injections can have powerful effects far beyond what was originally imagined… </p>
<p style="text-align: justify;"><em> Dr. Yéssica Sánchez &#8211; Neolife Medical Team </em></p>
<hr>
<p style="text-align: justify;"><strong>Less Inflammation, More Vitality, and… a Healthier Heart</strong></p>
<p style="text-align: justify;">Chronic inflammation—a silent process we often don’t notice but that progressively damages the body—is one of the main accelerators of <strong>aging</strong>. It&#8217;s involved in diseases like Alzheimer’s, certain cancers, and cardiovascular conditions. </p>
<p style="text-align: justify;"><strong>Semaglutide</strong>, commercially known as Ozempic® or Wegovy®, not only supports weight loss but also significantly reduces inflammation. Studies have shown that it can lower inflammatory markers (like C-reactive protein, or CRP) by up to 43%, even beyond the weight-loss effect. </p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-1057 size-large" src="https://www.neolifesalud.com/wp-content/uploads/Semaglutida.png" alt="Semaglutide" width="1024" height="683"></p>
<p style="text-align: justify;">This anti-inflammatory action is especially enhanced by the reduction of <strong>visceral fat</strong>—the most dangerous type due to its strong link to cardiometabolic risk. For this reason, semaglutide is increasingly used in people who are overweight or obese, even if they are not diabetic, as part of a comprehensive strategy to improve metabolic health and reduce systemic inflammation. </p>
<p style="text-align: justify;"><strong>Semaglutide</strong> has been shown to reduce vascular and cardiac inflammation, improving endothelial function, decreasing leukocyte (immune cell) adhesion, and lowering the expression of pro-inflammatory molecules like ICAM-1 and VCAM-1. It has also been associated with reduced myocardial inflammation, which may help reverse microvascular rarefaction (the loss of capillaries and arterioles that impairs microcirculation and is typical of metabolic syndrome). </p>
<p style="text-align: justify;">All of this translates into less arterial stiffness, improved tissue perfusion (blood flow), and a reduced risk of cardiovascular events, such as heart attacks. Moreover, several studies have demonstrated that <strong>semaglutide</strong> lowers the incidence of major cardiovascular events (cardiovascular death, heart attack, or stroke) in people with obesity or type 2 diabetes. </p>
<p style="text-align: justify;"><strong>Brain Protection</strong></p>
<p style="text-align: justify;">At the brain level, multiple studies suggest that these treatments may reduce the risk of cognitive decline and Alzheimer’s—even in people without diabetes. They are currently being investigated as potential allies in preserving memory and preventing <strong>age</strong>-related brain damage. This is largely due to their ability to reduce vascular inflammation and restore the integrity of the neurovascular unit.  </p>
<p style="text-align: justify;">In animal models, GLP-1 receptor agonists reduce amyloid plaques, neuroinflammation, and induce changes in microglia that promote a neuroprotective state. Additionally, observational clinical studies in people with diabetes show that semaglutide is associated with a 40–70% lower risk of being diagnosed with Alzheimer’s. In older individuals, GLP‑1 use is linked to lower incidence of 42 chronic diseases, including dementia. </p>
<p style="text-align: justify;">One of the most interesting human studies in my opinion is a pooled analysis of seven clinical trials involving 1,094,761 patients (both men and women around 60 years old), selected from a U.S. patient database and followed for three years. The study cohort included 17,104 new semaglutide users and 1,077,657 new users of other antidiabetic medications. The efficacy of semaglutide was compared to each of the other antidiabetics studied.  </p>
<p style="text-align: justify;">Despite significant heterogeneity in insulin and semaglutide receptor profiles based on ethnicity, age, sex, obesity diagnosis, <strong>cardiovascular disease</strong>, and Alzheimer&#8217;s risk factors, these groups were balanced using propensity score matching. Patients with type 2 diabetes prescribed <strong>semaglutide</strong> had a significantly lower likelihood of being diagnosed with Alzheimer’s during a three-year follow-up visit compared to those prescribed other antidiabetic medications—regardless of sex, gender, or obesity status. In fact, the overall risk of a first Alzheimer’s diagnosis within three years was nearly double in the general elderly population.  </p>
<p style="text-align: justify;"><strong>Cellular Energy and Metabolism</strong></p>
<p style="text-align: justify;">These therapies optimize how our cells use energy, regulate insulin, and protect the mitochondria (the “powerhouses” of our cells)—all essential for slowing down <strong>aging</strong> from the inside by promoting a healthy metabolic environment.    </p>
<p style="text-align: justify;"><strong>So, Are They Just for Weight Loss?</strong></p>
<p style="text-align: justify;">Given all the points above, the answer is no. While they were initially introduced with that goal in mind, scientists are now studying them as potential <strong>anti-aging</strong> tools. In the future, they may become part of <strong>prevention</strong> programs <strong>targeting brain</strong>, <strong>cardiovascular</strong>, and <strong>metabolic health</strong>. </p>
<p style="text-align: justify;"><strong>Should I Take Them?</strong></p>
<p style="text-align: justify;">Should I Take Them?<br />They’re not for everyone—but they may be worth considering for people with obesity, prediabetes, insulin resistance, or high cardiovascular risk. The decision should always be made together with a physician who can assess your case individually. At <strong>Neolife</strong>, we’d be happy to guide you and personalize this treatment to suit your needs.  </p>
<hr>
<p style="text-align: justify;">BIBLIOGRAPHY</p>
<p style="text-align: justify;">(1) Estato, V., Obadia, N., Chateaubriand, P.H. <em>et al.</em>Semaglutide restores astrocyte–vascular interactions and blood–brain barrier integrity in a model of diet-induced metabolic syndrome. <em>Diabetol Metab Syndr</em> <strong>17</strong>, 2 (2025).</p>
<p style="text-align: justify;">(2) <a href="https://alz-journals.onlinelibrary.wiley.com/authored-by/Wang/William">William Wang</a>, <a href="https://alz-journals.onlinelibrary.wiley.com/authored-by/Wang/QuangQiu">QuangQiu Wang</a>, <a href="https://alz-journals.onlinelibrary.wiley.com/authored-by/Qi/Xin">Xin Qi</a><em>, et al</em>. Associations of semaglutide with first-time diagnosis of Alzheimer&#8217;s disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimer’s &amp; Dementia. Vol.20, issue 12 (2024)   </p>
<p style="text-align: justify;">(3) Meca AD, Boboc IKS, Mititelu-Tartau L, Bogdan M. Unlocking the Potential: Semaglutide&#8217;s Impact on Alzheimer&#8217;s and Parkinson&#8217;s Disease in Animal Models. Curr Issues Mol Biol. 2024 Jun 13;46(6):5929-5949. doi: 10.3390/cimb46060354. PMID: 38921025; PMCID: PMC11202139.    </p>
<p style="text-align: justify;">(4) Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, Ouyang C, Liu X, Liu C, Chen Q. Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats. Front Pharmacol. 2023 Aug 28;14:1146960. doi: 10.3389/fphar.2023.1146960. PMID: 37701028; PMCID: PMC10493299.    </p>
<p style="text-align: justify;">(5) Shayan Yaghmayee, Atefeh Sadat Moazzeni, Tannaz Jamialahmadi, Sercan Karav, Habib Yaribeygi, Prashant Kesharwani, Amirhossein Sahebkar, Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying molecular mechanisms, Neuroscience, Volume 579, 2025, Pages 187-197, ISSN 0306-4522</p>
<p style="text-align: justify;">(6) Zheng, Z., Zong, Y., Ma, Y. <em>et al.</em>Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. <em>Sig Transduct Target Ther</em> <strong>9</strong>, 234 (2024).</p>
<p style="text-align: justify;">(7) Wang, W., Wang, Q., Qi, X., <em>et al.</em>(2024) Associations of semaglutide with first-time diagnosis of Alzheimer’s disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. <em>Alzheimer’s and Dementia</em> 1-12. </p>
<p style="text-align: justify;">(8) Papakonstantinou I, Tsioufis K, Katsi V. Spotlight on the Mechanism of Action of Semaglutide. Curr Issues Mol Biol. 2024 Dec 23;46(12):14514-14541. doi: 10.3390/cimb46120872. PMID: 39728000; PMCID: PMC11674233.    </p>
<hr>
<p>La entrada <a href="https://www.neolifesalud.com/en/blog/prevention-and-anti-aging/small-doses-big-effects-glp-1-and-longevity/">Small Doses, Big Effects: GLP-1 and Longevity</a> se publicó primero en <a href="https://www.neolifesalud.com/en/">Neolife</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">29274</post-id>	</item>
	</channel>
</rss>
